{"schemaVersion":"peptidescanner-clinical-trials-history-bundle/v1","canonicalUrl":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json","manifestUrl":"https://peptidescanner.com/clinical-trials-history/v1/manifest.json","peptideSlug":"liraglutide","addressing":"objects is keyed by the lower-case NCT number. A URL fragment #<nct number> on this file names one trial's history object.","objectCount":77,"objects":{"nct00318461":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00318461","recordId":"NCT00318461","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00318461-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct00318461","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct00318461"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2006-04-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2006-04-25","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"3b81236f31434866b5ad948165f6fa1aafccdcf276a71ce5ffb4f9fc62e8fcb3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2006-05-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2006-05-30","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"cefaddcdea830d81d5f3fd1ab4831b99eec5d2babff43029e2881de8197b55f1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2006-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2006-10-10","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"4b5a6981cf3ee8591d01aba9b87232298a3f5139b65d0ca7cf5aac75ad63fd3f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Outcome Measures","Study Description","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2006-12-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2006-12-11","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"8f2343ebe95ea924e4e052c13a53ef6c050c8f1a3e34a8272cfdb25a18f15137","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Conditions","Contacts/Locations","Outcome Measures","Oversight","References","Sponsor/Collaborators","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2007-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2007-12-19","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"b4a49fd4e50bf13b6f38657d02d88a723686f80e368cb2969fe341cdb497225f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2008-02-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-02-15","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"e25605a71bbb72ed58edfd5bf091b4c896465ce356710113c2149a8682251cde","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2008-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-09-16","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"47e05af9035fb270bff0d96707a035f7150f9db9e45b2a83abff029d1a1a9e02","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2008-10-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-10-15","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"a29b51279e9859e344abeaa2006f8902207dc502b1cd9e75dca728d5b48b024a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2008-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-11-05","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"fa732f86558044f411292518673f8ad17fd0393402d62df261f692b17ff79e7f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2008-11-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2008-11-20","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"eec15e3d266819c5e8e2ecdaf7ebbdde00b34a6be1b479901f92f3c8b95edf8e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2009-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-03-04","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"801b6de1fd8645d0f23ab94f72cd29c6e382aa85384310c5a7329cc4f3bd2097","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2009-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-06-10","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"9b52bff06221c078c7e2c9532b9e001749c84e90778a3d6c57e9b3e9291eb306","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2009-10-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-10-13","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"77c9fad11b30542b8b4c7ebc838eb2db0a8bc9d334257b929ba65c1af709fb8f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2009-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-11-09","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"00c80649e4f5f74c855b5a2cea20b7dcc16167008459813f6e0fcba2234f80d5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2010-02-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-02-23","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"2aa9d66281c23974c0092373a00cb123946967baaa8e4d4c94d3d7a305cc7bc2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2010-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-04-16","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"d65b1ac23320954d1ea90733ecad1cd92695e8eddac8209f56ba3353caac2000","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Conditions","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2012-07-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-07-09","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"2d555f1200386f440877c8750fb47222acd257652aaf9828d35bbb951bee5d7a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2013-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-11-25","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"b8f4e062dc42637b7a9b188d1f46365da57dae781969b248d26bbb4c09fe7295","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2014-10-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-10-14","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"e1d303b5041d00a21e64a667b7b664c81e3651f80e2d7a6616cebbf7cef829b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures (Results)","References","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2017-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-24","publishedAt":"2026-08-23","recordId":"NCT00318461","recordSha256":"fef928e74432b2e816b4ac380b64fe49a98f9d73516740080e81fddd766538a5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00318461?a=20&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"003fd0a965ffa445cc0af0424838cf2ba1477eb061ca31cf2b617caed6d16514"}},"nct00422058":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00422058","recordId":"NCT00422058","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00422058-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct00422058","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct00422058"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2007-01-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2007-01-12","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"611e2f5ba142ecaf5eea2fcd4a0dc4a38e9ca727ec4026e416675265bf8b6e32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2007-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2007-04-27","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"731ab8f6e0130a02ce8dab8b87a34c708b2fe89e30a44b0d146c4ea27d755f3f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Oversight","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2007-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2007-09-28","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"c90198d4c51f24c62853049ef003cc1628835ef8e7b308cdadc5cd2af2260c01","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Design","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2008-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2008-09-16","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"9557ff7e2fccfeb48af1f3fa2775c81e1af40c47ea0ea0d9003801dff3e53f1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2009-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-06-11","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"ef696647e94b441c2a95a06395f4972f305b8830962fe2c8fbf63aea39d6e1f5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-10-05","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"8bff7ad48e9877e202fd3817bfe910ccb244d02c19df914fb56e3f8802356837","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2010-11-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-11-23","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"06d20dadae14b2bba3102f4f8c3fcd077fc138fec8c3e85d108b6e18642e4e54","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2011-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-02-14","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"5257bc54bb2dcd8ca80bb6c9ca791217775aff7ac859108c055b4da1a122a644","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2012-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-26","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"fb23717110d4cf17728d9785eb296210341077ef2edc4f65170662b04bc6be22","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2015-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-04-22","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"f841eb42779f64de32d8b6ff989d603a9f31fb915f6ef989967b3fe07fde4cdf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-09","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"37562113eeb1c1298bbf95b782066c1b6ad18358488b3808658aeb4e11fd0dda","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","References","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-17","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"58c1548c223215a4e2ec142177b8e618237bf16eebfbd7eb444b065885b320eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-29","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"56fc517b1d5010adbf5f87cc18070fb36aae39a1fde22e4ff2c5a154291e21ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=13&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"4763bc14ce1be1bfa6e0de3afa0e9367592b105e4464fadbf295ab873cf7348d"}},"nct00781937":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00781937","recordId":"NCT00781937","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00781937-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct00781937","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct00781937"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2008-10-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-10-28","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"a21d790f4bda2457f229b2fdadc46e4e97c7de8e8ed3863eec19f67a3284e5e2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2008-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-11-10","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"f7da63473b391b9f26bd63ea6bdd4a35e0dca97d11130867a7f039c0d800f088","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2008-11-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2008-11-12","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"de3199b1d9843384f966b98f84f42a5885024f22ce537945715802f31467e12b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2009-01-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2009-01-12","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"1ec9c78eefd64d95898366d55592faab14da25bb10fd76bf33980398af397874","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2009-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2009-10-30","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"48216dc7d612909d97a3023764c6209506c46d6c693d8c2902308f7c01712f16","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-03-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-03-22","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"477a36b5655956a377558ac16234b6d487c4c30126a6561a730fe69e1b49a69a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2010-08-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-08-27","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"47e23ec1a7b5e0baf898ab4f2290b3186a6c2d97d13c35b635da03ac4680f792","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2010-09-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-09-08","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"51ec428ab1e06f4daf8fa61c2060d70cfbc7e97201c43d0fd983bc8214abf881","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Identification","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2011-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-02-09","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"c77396e94aee4995d51da4d9ff07d40f9ddb1b64574c545ddf0db5d77c1e2072","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Identification","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2011-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-06-16","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"d7266dc9d93f89849daed17f71f9c6f09b8d48d2d4e1c64e2a3c5a9102c1be66","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Sponsor/Collaborators","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2011-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-10-20","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"9033394d90d9410461a9ce8aa82e0e8dac33e6d4fbceb4ef9c0d51fe16be2bfd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2011-11-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-11-30","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"8d61f29b9033a4c0ac55ae0e0076ec97d1ccf8c0a4eabc22523ed86da5a7f33e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Sponsor/Collaborators","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2012-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-26","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"ee5d422bebbc5d34e06c58bac01364c9d1e943e3f6297fdad0e9ff9c6cf1ba52","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2015-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-04-22","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"5df9fcf9337c64c4b9ecdfe30a2df6cd8d426a7e0599a67dc719a1fd92702b35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2016-08-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-23","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"d07a4ff0ddb0e2fb0ddaeb1f4d45520117204527bd0277aa67d41afe446e6812","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","References","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2016-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-12-15","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"20344b5d7f07f4b3ed9de5ecacf4a76bf896f22b3eacc11add394a7d358fe5f4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Outcome Measures (Results)","References","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2017-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-09","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"c8043ed2e85e2b6e24681cd02be81dcbb7fe340a26b2beee9682e1df2f93b4d6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2017-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-17","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"739773672ab8041a2bcbe93ae23f3e23ae1749956ad529b3192603dd1be82769","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2017-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-29","publishedAt":"2026-08-23","recordId":"NCT00781937","recordSha256":"43ab8408bdd7b415591a2bdaf881812195f42560479823d9a54a4576a4a2b084","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00781937?a=19&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"7816133f7ce1a5790bf8283dc12030ebd0b2785eda3358f2b5426b55ef7a2f16"}},"nct00873223":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00873223","recordId":"NCT00873223","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00873223-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct00873223","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct00873223"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2009-03-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2009-03-31","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"802b31fdd11e8de1ff64e2e26b3b533fa563627020356224859bcec537bc8d6e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2009-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2009-08-11","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"bdc1f5b1cf51ad0fd6ef2bdab3aac80405f37971aba06685f13a76088c778a85","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2009-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-09-17","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"42871cdbe4f106acdb785d100f0d2ee6624fb1eeed8c6576665e3528d82ff5c1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2009-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-10-20","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"292b265f3a8743e324bf4886289d88df3811fb6de92974dd523c52a52edaabbe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Sponsor/Collaborators","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2011-09-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-09-15","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"eec189139e297483988eabda7f05572e76a08f9f53a8368be9de61820b39cf5e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Conditions","Sponsor/Collaborators","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2012-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-19","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"b32409317dddb318c38cd72a80e1e5ce857a2edd21f01888ad0596ea1ddec6af","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2015-03-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-03-23","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"3bf81d135ff328af9288a9d6ba2691a4592860e89d92a7cc2a4bdcd4e6714dd9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-01-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-25","publishedAt":"2026-08-23","recordId":"NCT00873223","recordSha256":"e259eae0a4c0056b51b6e14c5885daae48552c6b2342ac785c2d889c2c21f112","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00873223?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e12892872e892e559b9711f053d35de1a4da3f3af171d791740882cf81dbf95c"}},"nct00978393":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00978393","recordId":"NCT00978393","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00978393-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct00978393","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct00978393"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2009-09-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2009-09-15","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"64174e6e522d272021f020cc97961a99574535f45a6cbaae99ec503980e16158","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2009-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2009-09-17","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"77c2644de526b7686938ff2a8d31d720d0109f0720fe5739a939cb414a960302","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2010-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-02-12","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"b46e3fdafdbf4b380d25c9eedaf4a81543c105d3cd6a12a1f303fff9a65d54c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2010-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-07-12","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"b294c6231ff840864e0cdb35bf27f4ede1fa6013462ba965498423fb543e4ebb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2010-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-09-16","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"2fa5031c793f0f962518d2e755cabdbb73f1944e26458443c2a7e2b470a7f0d6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2011-02-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-02-15","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"3ed3254b91f16b85dc9e814bb60bffc5004daab7548cce8c6adf1d1b52941b27","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2011-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-06-17","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"30225e78da1c47a7acd42c31e63d975d246780c73a0f41197a8966e60f0530dc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2012-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-26","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"ab0418ed084a2c03ab6f4bb9325f0b36f5ea1502e22b93a8ca576d893cf099ea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2015-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-04-22","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"56aab8ab465e51507f3aad36be66d53463c4a65bccff7931ff96cc5abd7c5944","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-02-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-08","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"76bee9f4a94191edff27a23e5adff6eb90df6798906ff576c9fafa0bc7253498","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-07-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-07-25","publishedAt":"2026-08-23","recordId":"NCT00978393","recordSha256":"27334d03feb3b411c89c99cae70fae5d14fc4210802686abcbc8d46074159dc9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00978393?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ef0799c2df53ccef73a3f293b58908941f1d0f2a86f174795607bd8ee615f636"}},"nct01128894":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01128894","recordId":"NCT01128894","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01128894-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01128894","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01128894"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2010-05-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-05-21","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"32b504e0eafd4a4cbe540542f8640a0d5dfde291c5ca8afaa2547112e6d23232","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2010-06-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-06-03","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"6cc1246ebb4343547d1b6a300530bdc149d4ad8ea565e07ecaaf1ac1fe0a9bd1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2010-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-06-10","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"da09de41ea34eb2006a628e559ad464198f90f7579e19e04cac99c89cf4788c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2010-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-06-17","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"6825826b1a3f9154a52a4fa0f06ca663391187570f12e762fecec77bc2757724","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2010-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-07-01","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"4d2379e92dd44af535f592e4ef15af4318fd41a980902f205844cbb81d3e437c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-07-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-07-08","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"3ec068dff3a0052fab5a7a30e2dff2eb4a4c46e3052857863b1b148752c8786c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2010-07-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-07-15","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"3fd7125523a11745383f3f61e7d3a65cb8db9bec25b1d68a02c349cc1e704474","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Outcome Measures","Oversight","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2011-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-02-10","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"fee9ba3c1f1875b24ee1e5743807df1b05251fc52b27cc9e92521df4f0002534","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2011-04-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-04-14","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"5777e516d8b240cee88a76982c7d6b396d6ac9fc064b3abb9ee7bc7bfcd63780","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2011-05-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-05-12","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"342c684e528eccb794c2cef7ec486118af530e21366a17bc57febbcbd743bfc6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2011-05-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-05-26","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"9a734e3d4271e4cc3fe7a0ee0b91fc80a9e0901bc38e2f39601194bfe5dcf4eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2011-06-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-06-09","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"23b50c4c87d5a8f9e96f729e818d20ed1c06886a00ee2b05626ed9733b30628a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2011-08-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-08-04","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"64d0a1d8734adbec751e93eda59c6f681edccd489894b691cfb13d466ad6f118","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2011-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-08-11","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"59eca059518d8895e3536dfda0433c7ed55c6411db17949619b37cbc156fb84c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2011-09-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-09-21","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"e79d11a43d90d3e047db1b38f5bcb0872364b90dfda30d17407f76655ebccbc3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2011-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-09-29","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"1ea1b6cb816514a77167b732a1b9fd02f7ffbe787f0d927c6d5987825759d159","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2012-04-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-04-12","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"1e5012f2887649b9b15dad53446fe423944d4d11f5ce43ec0eb3fcc1e9311327","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2012-04-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-04-26","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"1a15552907280eb1644eda8cd137ab38058bb9a1bbf7ffdf7aa4853a4d6037c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2012-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-05-03","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"03e791a2fa3d90f3facf360616d78ecf208371ce9cb358e0a30adfb22de82cb1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2012-05-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-05-24","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"dd2bba7d406078d301e95be3fc15a77d7a860a71061822563835f4f277065e53","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2012-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-05-31","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"6774772d10849fa1b68212eaac35a7225baa4f9befe8921f5106795327c95476","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2012-07-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-07-26","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"aab24a4ca91747a6eaaa84505e0991c0bacf9fdaa4ae199ee1a263de5dc43853","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2013-08-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-08-08","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"5b5194917a80d87cb1264fb1d6d93c4d4b95d89067b6bf920440b19aa1a2ca2c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2014-02-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-02-20","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"4f75bd4e03cf3cf2bd0b1820bcd382d543d040c2e695a9410d6edea74f458086","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2014-04-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-04-17","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"8c49fa9001926a95cccff68b581cfb0879f775af0a186b0a9f3c36033ff5e30e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2014-05-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-05-22","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"7d204ce4a4c71d2087034ac6cb87e93fae240233a72931f21cd8b28f138ee3ae","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","IPDSharing","References","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2016-08-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-25","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"1cc05e9834806e71a3bbd13c51aff6861f3082b16049e8ff3b1998975c9bbced","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2017-01-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-09","publishedAt":"2026-08-23","recordId":"NCT01128894","recordSha256":"754d8010198ed36b54e07e064c1aaa65ab4b56c35928692a90c2ed78364acb7c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01128894?a=28&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"439a4744237beff249f5491f38661769cf96cfc8cb5a931bc33d5be4ea869587"}},"nct01179048":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01179048","recordId":"NCT01179048","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01179048-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01179048","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01179048"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2010-08-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-08-09","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"41aa0e15c81786936ee8d39855cdeead62c9fffcb544247ce04796fd39cae77e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2010-08-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-08-24","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"1a09f3d94a7770c04042e1a46988344d2e8b958129e7f86eb263ffbc893dab32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2010-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-09-01","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"a63c3ef093567a339805daaa7e5fdbaac112369d932ad3d57553280d53b775f0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2010-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-09-29","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"8abb0010bf643d3befd23401969d623729f49db8663c2c997079ef6ca164db9c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2010-10-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-10-14","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"fdb5461f6e96f2215594b4b053da3a010d10130942a83c315cffe4cedbfbfc70","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-11-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-11-03","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"481f42e2161246ce72b0bb272763d99344cec4e22df53f0ee53c686af3d9f73f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2011-02-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-02-08","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"01e4fb2e3cf518d29f6b20c957801e384d39de6735c574d645018fd35c04617f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2011-06-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-06-20","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"f92f8f35fa9e8bb2fd6097edc9a98eade366868e8324e207361afb8d7790f59c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2011-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-07-01","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"4e531b0162233818e64d1ff5d6e0cb3c208c4ac9e6e288781487aa7cd56c06b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2011-08-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-08-02","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"3acac858787aea8e2108115b3c547492dd661ea3cfb51f741d4c289d0b78e994","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2011-08-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-08-03","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"a7dd6a44bcaff5f03d5d4eb95afca90d6bf2269a6ccd12c2fb3227cace26e67f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2011-09-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-09-09","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"0612c98702382659379450718159fd9cb3029fe285794ac98ac1a1f88407cb83","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2011-10-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-10-31","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"beca7ecfb073d4ebc923dc8689b07a903227b5d36568d324f207d45166a7799c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2012-03-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-03-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"7710cc2374afe939abcbed5c28fd4e6951d0395f6f10b4c3ed576397df369828","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Identification","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2012-04-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-04-17","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"d024a37ab242bb53a136257ecd6f24e4bd3b17d8640e6bbe85aa267e9baabac6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2012-06-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-06-15","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"277cbc2fc10c6bba8c0a413b4bc852ff85903bc998fe96f27601e492b37367ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2012-11-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-11-14","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"01ffefe555f8bc988107228cb1851bfd425086bc9c5be0e60e9d1b2a08217fcc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2013-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-02-14","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"484dbbc87244f5ab1e22defb643dd4751e179c9cb6a6c74027abbac1e73e9d5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2013-07-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-07-18","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"242d0d661c9567be7339dec6e4868d9ec31d1b19ae91d72dd0eda4123572082e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2013-10-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-10-11","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"201ea79ab3d94efa565fcbc96b56e6959bd5ea0a4af0d959ac7ee0c6d3a18d37","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2014-03-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-03-10","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"8d0e444ebaf5ef4554d18956958a73ab1e05a554cd69a34d11c4ff63a128fa5b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2014-08-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-08-12","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"9d41af25959570d9e6c83df5cd4a7d5adb71d2e909972b73e21e75b52a923570","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2015-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"da9a1e04e4385de53aa49dfc08404acdc047adb95b1322d5dfa78d1e92c4004b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2015-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-05-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"de4c6f22ad3e381fd12b8b0377e8b4177db5c0de4c3990d54b747887ba4d34be","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2015-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-10-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"85d09056095b6420d1aac31812319826d8332bf12e1d26b5993959401d12d053","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Identification","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2015-12-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-12-18","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"3b49876143b18c97a7634d53891609c67d7e843062ea1d3e3d2aa6188566d72e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Design","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2016-05-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-05-10","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"ed9d2aaccd0d36b3b95e45240d6a30a9f0f9990e1f02eb8340b1c1cdeb448980","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2016-08-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-18","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"0baac34acdfaed35a9e9dab221a10f6b9c5f9ac27ea6a88d193e277df00a3a3f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2016-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-31","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"4b6da641094861d3c79f1bb41344236d2c0c02e22a207260bd7206709ef23856","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Oversight","References","Study Identification","Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2016-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-12-15","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"5c01227050ae80b1c5165fcbbebbea70d2ac0231ba20979b4a463efaf91c0fc0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=30&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Status"],"historyVersion":31,"lastUpdateSubmitQcDate":"2017-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-10","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"6e9642decbb5e9a8b679b5f6620d0146d457618594570a2be45fdfab7f60002f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=31&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":32,"lastUpdateSubmitQcDate":"2017-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-04-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"a039838a33eba6f2fe82062547030ade2a8a6f7926e07496552e861180f764b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=32&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":33,"lastUpdateSubmitQcDate":"2017-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-15","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"79d726e2df169406db565ffad6ad60185d7f7223ff08644981753e29d9812ec5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=33&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":34,"lastUpdateSubmitQcDate":"2017-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-01","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"b892df36590c2751f462a2d91e69613a6ff3e5fad1232865d12446ef01dde1e0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=34&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":35,"lastUpdateSubmitQcDate":"2018-01-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-01-11","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"f5c3fce413e562ffa68cfe55b650cbb4b6d15e336676066a697c9bc25d9ae6e6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=35&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":36,"lastUpdateSubmitQcDate":"2018-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-04-20","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"40e57fd2428aa528b87dddf6f2aa1c98f9456bd3cc7ca94e72877bcb28cd63e9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=36&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":37,"lastUpdateSubmitQcDate":"2018-06-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-06-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"e269f1921fc3f0772d7ad9da07281c4deac349b429beb3336a56418667673b75","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=37&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","References","Study Status"],"historyVersion":38,"lastUpdateSubmitQcDate":"2018-09-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-09-05","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"fb2e50d9a4eb0690f724546f20e99bdb144d78122c741a3b20bf4b649d847f33","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=38&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":39,"lastUpdateSubmitQcDate":"2018-10-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-10-26","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"dcfa4adfc656b18d2c7a6fdaee1445f980e207ce603669da7800b9359bd13adf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=39&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":40,"lastUpdateSubmitQcDate":"2018-12-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-12-07","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"11b167eb6d1fbfff437207606750d9267cc6c8b17eca45e4967d10409fd82874","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=40&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Design","Study Status"],"historyVersion":41,"lastUpdateSubmitQcDate":"2019-05-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-05-28","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"f7095aee91337a5a37f15e72d173611740a3f97f28318d44ebec94fb8a4fa88b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=41&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":42,"lastUpdateSubmitQcDate":"2019-07-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-07-03","publishedAt":"2026-08-23","recordId":"NCT01179048","recordSha256":"8d6ddf497533393900c72a6d0e809a6588b7ed477dfb8a554caff8cd66107c31","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01179048?a=42&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"67c6739dbac7d532c4e0e842387d1e17fdcd8dfceb4d864969393425db52c154"}},"nct01237119":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01237119","recordId":"NCT01237119","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01237119-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01237119","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01237119"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2010-11-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2010-11-08","publishedAt":"2026-08-23","recordId":"NCT01237119","recordSha256":"f4ebc4753a007094a6f9eea6655a873d3fc78be344f947bb58070647b73ffb05","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01237119?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Eligibility","Outcome Measures","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2013-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-01-21","publishedAt":"2026-08-23","recordId":"NCT01237119","recordSha256":"256025f96d767bd1a4aed7020c0caac32b4f14b49c6e561a5d0d3eac4aa0a179","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01237119?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-10-10","publishedAt":"2026-08-23","recordId":"NCT01237119","recordSha256":"6aed143f886f9ae4c74024d0a1f30b8a36bd4c95a3d91682ff611d93107fbe78","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01237119?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-05-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-05-26","publishedAt":"2026-08-23","recordId":"NCT01237119","recordSha256":"495b2e12a40c51c0c6b3fe9ba695e8ec8211cca092f76bfcefb00df831594e0f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01237119?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2015-12-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-12-01","publishedAt":"2026-08-23","recordId":"NCT01237119","recordSha256":"23df9d5a7f1aeb87909e932b5e829145ba3e43f6530a78cd052dea8ede357d39","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01237119?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-03-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-03-22","publishedAt":"2026-08-23","recordId":"NCT01237119","recordSha256":"05db926170bc5898175d0bdbd8785d2fdeb77e8d0517052b2167afdd292baf2e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01237119?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e80e8524b76907096a7ea8a246f1e85ceab6d9b4577d04447e9c428613423d0f"}},"nct01270789":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01270789","recordId":"NCT01270789","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01270789-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01270789","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01270789"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-01-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-01-04","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"e06d6b20de476b394e04537b6d06731918aadec61450bece8b0acfac8f44cfb2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-01-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-01-18","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"3d90727215c4f6dafa7320efe17443feca93407d74fd57a3b64413d0ca6ce8d4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2011-08-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-08-02","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"8a343eafd54fc7df96d29fca3b6351c6cd76944ac201f3fdffba02eb404d8140","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Sponsor/Collaborators","Study Description","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-12-19","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"f196602919524c01391369e851647a65617464e07a5279547716237362870265","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2013-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-04-08","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"7b6300d6b55524d5379dd97991571c56b2928d7a9801af95028102826d3a401d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2013-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-07-12","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"f6419dc3145c4dbcd082fa132ffe2ddad35f260c7d502eb814829f29e8a2813a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2013-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-08-15","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"8fb8ce7029e663ac6c5d03ab2d8ce906ca2b95b5a05c6d8ab7d32fb07dae4a98","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2014-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-09-10","publishedAt":"2026-08-23","recordId":"NCT01270789","recordSha256":"d7b2a910eb8ebaea073d51293fe80d755d250e666a33893c0546d1e8cdf6a6bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01270789?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"70f5f089d4c333e909ed2ade0830b2f0fcecbe8de0f0207d4b33c0e4de0536a4"}},"nct01272219":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01272219","recordId":"NCT01272219","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01272219-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01272219","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01272219"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-01-06","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"7a38757e3536c3ea6e23774885231b4fb9e738a52f7262ee2af3c7b02c948f31","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-01-07","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"b825ecb3bdba517db6ee20878d0a51e12f64b2aad64978e97c45d20cc189c25e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2011-01-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-01-20","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"1d8fac613852d6d128ed9070f78bbc04c4b9dd4fdf2f473b0520c2a1a827cfdb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2011-06-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-06-01","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"39565ea0bca1203cf732db9beee111f297b0e3fbdecc820e40d8fc2318895593","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2011-06-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-06-06","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"9a26945598588ecf854e856911d615ccb33a8008b91a6de635b8b258504de105","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2011-09-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-09-22","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"dea5bb16fbfb0612e198fee748989c3f90aa7a9e6084f232d186f811bbfb4de2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2011-10-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-10-18","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"cd423aca4a52622777342f6e6a2e57ec68b09771b569af24c90168b434f56153","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2011-10-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-10-21","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"133c298cde190c9d2eee62ef843ca6b156fe21c392c0c288ed419f65da32baa3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2011-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-10-25","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"30af54710cc877435392b30df31f37e230eddfd9fc89d789e379e5ef24e5ba66","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2011-12-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-12-21","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"e4555ce7f0a4014fc3af0d483aee92b4236ae46a58a802553e9e84f867b51587","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2012-05-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-05-21","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"776799cd91bb593e5af6cccd32a5c01749139d973cb4c81a56e7817168fdd090","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Sponsor/Collaborators","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2012-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-06-26","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"a0a6edefb13a936cb438076be9c5fe258593c2cbdd318be5dce57c6720668e32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2012-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-11-13","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"a4f2de2b50ea79d47b31a4100b8d6427d718eb3ba56178b3b0b34f92ec1a4a02","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2013-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-04-30","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"4bea7a566ef20c46d634fd2491ec91b48a8c356803b62a6ee1a7124968aaa125","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2013-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-09-17","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"ca8f0ad3ba446f88f8385f0bcee28388a66dc4ba9e9a4568ecb7e60225bb234e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Design","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2014-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-03-12","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"76929b80e386b9b120e6d4641e5662f44551ff8bd64fe62971b14527d74daf63","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2014-08-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-08-05","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"67606b4ebf1c413db15c07b71d858374af524b59bb1bc0fb2f411ebf74135e5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Eligibility","Outcome Measures","Study Design","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2014-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-11-13","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"77b88a4bd98c9009e56d715b35c52ff8d11d0858212b371615d99a3573c1a9c0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Contacts/Locations","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2015-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-22","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"3068c4ba86fe75051c87838e0b457a1075066b506ac099da38b1248aadd04a79","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2015-03-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-03-05","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"7fb1909e081386267255945838ae8e9b590e485cf656238718aa319e16c22041","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Contacts/Locations","Eligibility","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2016-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-05-03","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"ecc82b4855b75dd453c0f6e096f09852477dc5fbd4adb25b7e44bb0803de2ebe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2016-08-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-18","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"fa7c28c9d4f26a3cd6db380d5eea7c3f1eced40abbb10cd37a1a05cb10b25a21","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","References","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2016-11-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-11-07","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"852fa6dc5dc2ca6d519bf3a97fb783018acbc2a41b6fdd1ed52b8f862fbc53d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Outcome Measures (Results)","References","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2017-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-09","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"0ad9f9f1168e1a7f1336570eccd2147242e6032130990053b451f47c82d88b40","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","References","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2017-05-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-29","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"69e240c66d8aec597397862347a97bb1f377c47d20659bcb126f5da1397932de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2017-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-29","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"c218407d62725e15921d6d8ed796c83a08b861ff37c8af861005c29a3ce85821","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2017-12-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-12-20","publishedAt":"2026-08-23","recordId":"NCT01272219","recordSha256":"09103c906f96129d92f6fe41bc900c5d3bc8c896c4fa509083bed51c4b4f3288","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01272219?a=27&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"404c2fb5f16b3f0e2725e439ab7d542c8c31bc641533a2f011b1a1c8c2bde01f"}},"nct01394341":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01394341","recordId":"NCT01394341","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01394341-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01394341","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01394341"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-07-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-07-13","publishedAt":"2026-08-23","recordId":"NCT01394341","recordSha256":"de3c9a612eda2dfd822575c1830c8471fdb63e2d6b013ae4e6cb93c0aff9fc84","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01394341?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-09-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-09-26","publishedAt":"2026-08-23","recordId":"NCT01394341","recordSha256":"b6546ed45240cd2200e75b4cf7f2f6659a4ed5afc37335f25e46d6bc9710556c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01394341?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-09-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-09-18","publishedAt":"2026-08-23","recordId":"NCT01394341","recordSha256":"7efc10a4fd728bf746f155e43a7473b096765593bd6c669cb4197ae9919c49ab","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01394341?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2013-10-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-10-08","publishedAt":"2026-08-23","recordId":"NCT01394341","recordSha256":"546db957e8abb413aebb2645d80ae6b0967d4f97293ffd925007f878e9b8ab8a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01394341?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"59e9e304b5ea9ee23e67459411cfff5671197b85764c8f43569be7569a4b1f0a"}},"nct01469351":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01469351","recordId":"NCT01469351","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01469351-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01469351","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01469351"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-11-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-11-07","publishedAt":"2026-08-23","recordId":"NCT01469351","recordSha256":"d26a15164d696cb10c36d768652f8b4ecca00b1a009c3273f9483802d275b27b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01469351?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-11-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2011-11-11","publishedAt":"2026-08-23","recordId":"NCT01469351","recordSha256":"a94b89b113e683c1cab61b228898fa32a7de98881f334e030636e58c88c294cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01469351?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-02-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-02-13","publishedAt":"2026-08-23","recordId":"NCT01469351","recordSha256":"70c70258160c9a7ee30b197366bf590a088e9aa8944d7f01ba2163244cea3cf2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01469351?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-09-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-09-13","publishedAt":"2026-08-23","recordId":"NCT01469351","recordSha256":"f182f3777c79d47ff1c73645df4ccc0d13616d9e19de81b7c3b37ceb67630a94","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01469351?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2013-04-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-04-18","publishedAt":"2026-08-23","recordId":"NCT01469351","recordSha256":"5539d7b38f4ca82af5dd6c10700b36c8ae7c7e58e90aaf948fd377197f41b011","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01469351?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"411d92cf4fb18b6a343c014a9c0d2f153e1c7be2331d3e11985ffbcbe2c77d7b"}},"nct01507272":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01507272","recordId":"NCT01507272","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01507272-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01507272","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01507272"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-06","publishedAt":"2026-08-23","recordId":"NCT01507272","recordSha256":"f055fc4d9bf6c3b8c7d936ad80ee0a16eed82746bf0a3479eed8e65824d383ab","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507272?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-08-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-08-30","publishedAt":"2026-08-23","recordId":"NCT01507272","recordSha256":"7b305d35d25d9f911928c853359a819e779c62684a68cb6a6cc6c8312e21a56b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507272?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-04-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-04-25","publishedAt":"2026-08-23","recordId":"NCT01507272","recordSha256":"258a74c2a17f6cc4347549c5fe89f9cfa6f0484ce27bd50e5a58408d5de21c15","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507272?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-02-18","publishedAt":"2026-08-23","recordId":"NCT01507272","recordSha256":"78043dd5c0ed421fac8c2005e324697135405a67d2aaef6db3236503fad9652a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507272?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","References","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-23","publishedAt":"2026-08-23","recordId":"NCT01507272","recordSha256":"d88f40aedb6e02ef47d084535e9b262ed80036d372f3bab05554df6fb696a7c6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507272?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b04ec4d79f1052e0142605e05a4ee86b8f0bd00839cb60811846377cb9ed27fc"}},"nct01507337":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01507337","recordId":"NCT01507337","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01507337-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01507337","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01507337"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-06","publishedAt":"2026-08-23","recordId":"NCT01507337","recordSha256":"c93ffad9c0a372ed9bcbec4c869fdf2910c6c906de6d0199d122bad569769bff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507337?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-23","publishedAt":"2026-08-23","recordId":"NCT01507337","recordSha256":"97cf50f33ffb8ed470488730c8f0422c28580f018ecdef85c3ac2a556610ccb6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507337?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f2ff864b566cf726b6116a27b76b61e8361f716788daf88f5886cd8409b6f11b"}},"nct01507389":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01507389","recordId":"NCT01507389","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01507389-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01507389","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01507389"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-06","publishedAt":"2026-08-23","recordId":"NCT01507389","recordSha256":"58cf3b3c38cfcd52e418651d32f3ca8d03ab7e2871d8fd8c5d51cf99e3f143ef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507389?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-03-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-03-26","publishedAt":"2026-08-23","recordId":"NCT01507389","recordSha256":"59fd9b2634a5226b50bddbdd0a7b7d83d34e722e243e97b31c0f1143a7d334cb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507389?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Design","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-12-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-12-08","publishedAt":"2026-08-23","recordId":"NCT01507389","recordSha256":"0bb84ee7641f115417a654f42c457a712e298f15e2923542a75dca04f708f163","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01507389?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"899b1a519301f3cf07018cb6b2959eea47f6e8dfd15dda64b54240101e3298c2"}},"nct01508806":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01508806","recordId":"NCT01508806","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01508806-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01508806","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01508806"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-09","publishedAt":"2026-08-23","recordId":"NCT01508806","recordSha256":"0a2ad5520b24b501357a9b79a511c5a84623a8b36bf5d7f33da4951efe42dda5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01508806?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-01-22","publishedAt":"2026-08-23","recordId":"NCT01508806","recordSha256":"010179f566aa067da7758668ef005ad107aef74402b8f4db0abbea776723d01e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01508806?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-23","publishedAt":"2026-08-23","recordId":"NCT01508806","recordSha256":"386adbf34f9187fc085f455ae1da6396af466aab2fffd8f6ec2274a860bc452a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01508806?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f4cac31201604ff80be5a977b57e4b75fc18e98e6e44af917b90186dc7001307"}},"nct01515592":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01515592","recordId":"NCT01515592","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01515592-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01515592","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01515592"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-18","publishedAt":"2026-08-23","recordId":"NCT01515592","recordSha256":"5acf943c917a76406a99e83a245908e9e5b3696651a238075f593cb310a50206","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01515592?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-12-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-12-10","publishedAt":"2026-08-23","recordId":"NCT01515592","recordSha256":"0b05dc414092812f0baa483886b4ec7a7ef60b2d578171e0f3a382e30f6f86d5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01515592?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-24","publishedAt":"2026-08-23","recordId":"NCT01515592","recordSha256":"d0f4d8c6b554bed5e57ddaa9719627a5131567347b7c560b0c7072a4aca0e137","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01515592?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b1e901b24d179a5eef524f2feb9519237278d3a6f2a3456c9f5592d54f1df64f"}},"nct01516255":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01516255","recordId":"NCT01516255","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01516255-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01516255","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01516255"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-19","publishedAt":"2026-08-23","recordId":"NCT01516255","recordSha256":"c15fe8c25f369b30ce4e3726067780eeda22b09905b5f0e7d5c5fc0dd2060c2f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01516255?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-24","publishedAt":"2026-08-23","recordId":"NCT01516255","recordSha256":"0e9f8cbe02d3c6a5424812d8ed06c9cbc1c79512d163d74f2e7803f032c416f4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01516255?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-08-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-08-30","publishedAt":"2026-08-23","recordId":"NCT01516255","recordSha256":"10db1076c6ae9a5611d083d4d7286efb403271e4879f5608fa442925cc0aa556","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01516255?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT01516255","recordSha256":"7a6fdd55460afa9e25e4815b49ac424675334c504cf89b0dd9eea56f89b37197","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01516255?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-24","publishedAt":"2026-08-23","recordId":"NCT01516255","recordSha256":"bd5f63305c86b113c8e95f88f970313a54ce160df175b2a4c81634db359c4b32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01516255?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ddc0bbbf8c0aa73b5ffb10007fe35025775ab5421bc882c6369590aa2d5b0d42"}},"nct01518101":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01518101","recordId":"NCT01518101","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01518101-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01518101","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01518101"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-01-24","publishedAt":"2026-08-23","recordId":"NCT01518101","recordSha256":"da493ce5060b558b88923a1a9e0d462fca30dd4dffb1f6d264d8cad3c7e3b5bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518101?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-10-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-10-08","publishedAt":"2026-08-23","recordId":"NCT01518101","recordSha256":"3239dc027b9fe2aa2396561e7c49660f6a2f94ccec98b2989704333e99084915","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518101?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-08-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-08-16","publishedAt":"2026-08-23","recordId":"NCT01518101","recordSha256":"9cea7a409bc51d483972a617ab6fec8f15c94b2e77c55d36bdddb58947b1ad90","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518101?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-02-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-23","publishedAt":"2026-08-23","recordId":"NCT01518101","recordSha256":"d35ca79e553e87a6a6eef5f5aebcb7ee7ba3742aec6fd6094a379505079a7cb6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518101?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"51704b2fa2a30bc05bdeb9e4d0d04c6e98da07e32fbaa3a1989e6e2717906302"}},"nct01518166":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01518166","recordId":"NCT01518166","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01518166-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01518166","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01518166"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-01-21","publishedAt":"2026-08-23","recordId":"NCT01518166","recordSha256":"4b7b3845a29d5de5299c29addd685f743d76824cef4bd9f891cb512a26fdb7de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518166?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT01518166","recordSha256":"d3255efa267b4fb5c4901af71253b11dae8e25b3854492061f593eafd322b705","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518166?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-24","publishedAt":"2026-08-23","recordId":"NCT01518166","recordSha256":"1f25e70d76445c9f14606dacd57d5589550ee95e3528626d9daf1d4daff93db8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01518166?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ca172e95e12bbdf779dc36e5527dd16e7a6f4d554340b386e0e6055c93951d99"}},"nct01550653":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01550653","recordId":"NCT01550653","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01550653-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01550653","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01550653"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-03-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-03-07","publishedAt":"2026-08-23","recordId":"NCT01550653","recordSha256":"c30d10e0ebd96d9aa337c84c54a71e80c8f99d10b3d16ae7ca1721414b1430d7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01550653?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-09-01","publishedAt":"2026-08-23","recordId":"NCT01550653","recordSha256":"0d14ed44519449042c2fb63072bc3b51ba026e7e80fa0f08b2bf755950ed52c0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01550653?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-02-26","publishedAt":"2026-08-23","recordId":"NCT01550653","recordSha256":"3db24e7aff72aef299e095d984a445187ad0b27aab513a16cdf51059d36b8b07","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01550653?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"5b6c4c19b0955a4c89a408730e8aa381f930cd2362df98785a21eabd573cfb56"}},"nct01557166":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01557166","recordId":"NCT01557166","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01557166-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01557166","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01557166"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-03-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-03-15","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"3a546e5c8d31d1bbd7d167955fd0aabc2429fec5a0e6e485c2b3125456f44ddb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-03-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-03-19","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"bac9a30f0554031cab4cfcf33c844a160639573c113665b49c1e5316fabf62b1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-04-20","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"119c054d37f2806db11642a9bbd538ea436a14ea10fcc10b40c1e813fa1e5cde","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-06-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-06-04","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"129df9151fa3bbc45578234ea2f1fc36ddc01a88b2c7330f84f44db39abe0258","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2012-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-06-08","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"fcafaaa016c0d9a04020300460d177552a8d382abd900e93d0d947416fde63de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2012-06-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-06-15","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"ea91bd443e1b1aa86cd24b1b5a8a84aec7f55b1fff0531d73c585370e8f091d7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Sponsor/Collaborators","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2012-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-06-26","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"45b2cc99641989313dccb5f3cf857441bc857564b00b94175c6ef7b70564f9a5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2012-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-07-16","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"548f6974b9a2f268ae6b2042fae7c658e564d27cc5d7c5013cdc907f5c13ff29","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2012-08-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-08-02","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"a1256d6aac44d2fdb1b8e6340ba0d54ff81f39db4bb4aa8e55a4bca5d62f3211","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2012-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-09-10","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"760dfe9c6755f885f278e0344be48e3b6a0a91f3b65023b0ddfb449dc7ea20a7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2012-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-10-05","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"3c7f59858e8c2b1b71cd20dd63861b53a115ff4af5474e95818237438cd26cd4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2012-10-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-10-09","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"ed1f339f1233f320ce5cb004c7a1ab04e69f972216734fe399f5469bf7a791f6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2013-03-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-03-06","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"e9224c884a97a71004820a7f66b91fc86994de9c754e9b7912e341a0acbf63dc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2013-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-06-19","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"487a6f740e4f6bec30417716bb21fb8b0175f7a6d35b78f83810d7ac9bf5098e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2014-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2014-06-10","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"64655fd67378d4e573dff8aa737a3dbbfb54a54d9361884278bd7f503b91107d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Contacts/Locations","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2015-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-01-22","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"d92b89e44561b83cb3eef503cb63077564880b9aaa05fecea40d3991ed81f750","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2015-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-02-12","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"fffc0a53689d86028f9b58752091f26da945b4a60207d23cbd1a84c2d5227ac1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2016-08-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-23","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"843e2368d4a0f247ae5ee639cbb5b946f71c06c1b59c8e745d7d82429d09c023","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","References","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2016-11-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-11-11","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"464979322af83f0a9af002e9e4f0f7c8a47012c2452d72f41aec33f6f6002829","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Outcome Measures (Results)","References","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2017-02-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-08","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"d28b025a15e88e25ea6133761fa485d36646279d11bc16d63bb36b34065a418b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2017-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-17","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"2f9b71d2b7dd09f8df4da3cd83d1c38e366a9926507bc9a5bdc1b5ebc9c6724a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2017-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-29","publishedAt":"2026-08-23","recordId":"NCT01557166","recordSha256":"2f031b6e49673a2058c94f3fe6c3a03ef38f303f290ca9f0bb9d4f23c31ec7b1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01557166?a=22&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"bc7f5f703de24b94c77c6ff986ad39f7d85f63d4078366aa9f710b08945833b3"}},"nct01562678":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01562678","recordId":"NCT01562678","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01562678-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01562678","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01562678"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-03-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-03-23","publishedAt":"2026-08-23","recordId":"NCT01562678","recordSha256":"f92d973d9704cbec1674f39455f1a0b7303ec6dd6af77c5b819a14fe6528b176","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01562678?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-03-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-03-29","publishedAt":"2026-08-23","recordId":"NCT01562678","recordSha256":"adddeb1e9c493bbcf0884f9f356b1fd71d2c9fdf3f1495fdf95da90ea76ef4b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01562678?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Eligibility","Study Description","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-02-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-02-19","publishedAt":"2026-08-23","recordId":"NCT01562678","recordSha256":"6d5f8e2fb02fe432bbd7a995efa509b60c429c637ca742e87770da3cc93a330d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01562678?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-01-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-01-12","publishedAt":"2026-08-23","recordId":"NCT01562678","recordSha256":"ab3ba8b9e4a9a011cc6cf4195ed9b556051751c891ead082f862abbc691afda2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01562678?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Sponsor/Collaborators","Study Design","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-04-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-04-26","publishedAt":"2026-08-23","recordId":"NCT01562678","recordSha256":"103497f83a7be45b1aababe3ca6f3a7734d9102cd2157bb296f74144e8c04763","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01562678?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"eb28dec7a74dc1704ad9f2fa08c99347bbf96ae0f269cb2edc3d1e2f3ddde188"}},"nct01620463":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01620463","recordId":"NCT01620463","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01620463-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01620463","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01620463"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-06-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-13","publishedAt":"2026-08-23","recordId":"NCT01620463","recordSha256":"a07aec4454a9b8c6ae146b83d83587d9bf433c0ee95387ce860fbcf47d4771be","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01620463?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-03-25","publishedAt":"2026-08-23","recordId":"NCT01620463","recordSha256":"784ad6b20ae7f3a18cb2794be2691cba6919d99b9053378bca2d370ad9a8ad7b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01620463?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-23","publishedAt":"2026-08-23","recordId":"NCT01620463","recordSha256":"074de96470645f5b52f8d586a34d1284fb09291b1cfa6e8cd0f601683c2ced2d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01620463?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"cdf0e15646701a5519751ac91e8c4d24ae942b58c0696814cc71d49940aa5ace"}},"nct01620476":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01620476","recordId":"NCT01620476","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01620476-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01620476","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01620476"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-06-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-13","publishedAt":"2026-08-23","recordId":"NCT01620476","recordSha256":"e5fbd379e0bea596a03ad3acc101cb3883dc929779a9e0d8f3f52d6f26c1ce84","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01620476?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-01-24","publishedAt":"2026-08-23","recordId":"NCT01620476","recordSha256":"f8171c688b443853c97b33b9c63eccfe5a09b0c58c6d6e89abaa677fee9de83f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01620476?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"9c72ff62faa2d5da1bd9cb53431e8fde5b7fc97c32779c14439a96645d8ecf3e"}},"nct01695109":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01695109","recordId":"NCT01695109","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01695109-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01695109","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01695109"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-09-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-09-26","publishedAt":"2026-08-23","recordId":"NCT01695109","recordSha256":"1f09a07540e391820d70819c6e95d211890b1ffa4f0a4c5ff5649d1f01ff437a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01695109?a=1&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"77ff75d370b4bde4282577b5dc8b15993b024cfb6881574382d985178f3f8642"}},"nct01739049":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01739049","recordId":"NCT01739049","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01739049-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01739049","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01739049"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-11-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2012-11-28","publishedAt":"2026-08-23","recordId":"NCT01739049","recordSha256":"298881e43c0b881db6a7859faf7e158c6d7bf9f4c0c02269c8ab2649856654fe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01739049?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-09-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2014-09-30","publishedAt":"2026-08-23","recordId":"NCT01739049","recordSha256":"8f61fe5f1bd9e12818d6c1010a448327820b3a0f7582e0c3fa06934a90412919","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01739049?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Oversight","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-05-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-01","publishedAt":"2026-08-23","recordId":"NCT01739049","recordSha256":"6a433e3ccda0e8d9037df9d1c25d878b0142044795a551307749072597c1a62f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01739049?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ce0ed99ddcd3c9a02d8e569ea39ebce54ab1535332d469dccffdab446d6dc2f3"}},"nct01755572":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01755572","recordId":"NCT01755572","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01755572-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01755572","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01755572"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2012-12-19","publishedAt":"2026-08-23","recordId":"NCT01755572","recordSha256":"9d093eab5c330fa3b8f5f443d8a53abe7790cab38888bcee43a6fb4d1432b08b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01755572?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2013-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-04-22","publishedAt":"2026-08-23","recordId":"NCT01755572","recordSha256":"c5cc2e9955ed9498e2af19d354babf517a8f2c69de2724deecd3cde618023451","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01755572?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"47711d1748aff1ed2dd78edb5a7bfb4809a6da491540e795243caf7fa282051e"}},"nct01779362":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01779362","recordId":"NCT01779362","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01779362-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01779362","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01779362"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-01-28","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"7cc9503156a26812850fb9c37382e0df857d0d15a6c11dd0dbe62e3334f06253","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2013-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-05-23","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"6eac169e950e38c71a3529532d17eda56637c592b942a09385cdda930fcc19fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-12-19","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"9d8a3768f0ec4c71f66c608c5031e75a3004385f27390ae4857cec637a2b6c35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2014-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-11-05","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"86149152757b4679c98f1b7f3e0b3235213aa8a9d86cb46472564ce7d2423d63","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2015-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-07-16","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"a71c549897d1911b03664d6b91cd73f123421ade35d3470708a4d47843fc29d7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2015-10-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-10-26","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"a7b473d5bf900480ee401ecc767d1078a44b85a2f0447212c8a6af6802d36e7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-04-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-04","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"cecd2dd18deef48ce06d284c2a38aa263114d5974a72cbed9d4a26bd7f1961b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-03","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"b9a1c6f661889b71fc7ae2b65a22f57e63e7e34c05ab3df97678992d665a17da","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2018-08-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-29","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"c512eabe4ebc6dcb6d5cae5cc624d393010341bd3f348e9dc1083202c7583825","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2023-04-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-04-12","publishedAt":"2026-08-23","recordId":"NCT01779362","recordSha256":"774ca6399dcc65f888782caa191b18e05e6818523309ef404c1778e6a66278c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01779362?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"26677c9025b7dd369ae0c0b0796b9f539e6c2a785971162ffa2b612b6b90d847"}},"nct01782261":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01782261","recordId":"NCT01782261","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01782261-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01782261","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01782261"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-01-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-01-30","publishedAt":"2026-08-23","recordId":"NCT01782261","recordSha256":"f014b2744cd45fcfd142fbdca9d4e0c3109965a2090e8bb69fc98af160e7b808","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01782261?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-04-03","publishedAt":"2026-08-23","recordId":"NCT01782261","recordSha256":"bb373cebb2962e15f348c85e6bd19f30791a1a081650aceb08480e2026a8c1f5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01782261?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-04-16","publishedAt":"2026-08-23","recordId":"NCT01782261","recordSha256":"a208528d02680b0d5afd0058d651019fe339ccd7444e50c7b719f3278d8bf3c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01782261?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-10-10","publishedAt":"2026-08-23","recordId":"NCT01782261","recordSha256":"6c6ffb9b3d9c708db55f0af42c65fd2a14df900a34355e28a152dfa4b7745097","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01782261?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"be7e015cc501788601da455fd15cc333b60527d872c9fb6470004bcfd4fe5b99"}},"nct01785043":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01785043","recordId":"NCT01785043","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01785043-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01785043","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01785043"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2013-02-04","publishedAt":"2026-08-23","recordId":"NCT01785043","recordSha256":"3d44f14ae21dda0354eec2b11e07debe8c496e23cbf19fea6f41b7b9b54df7ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01785043?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-09-01","publishedAt":"2026-08-23","recordId":"NCT01785043","recordSha256":"9a00e60d3dd4b8b3ccd5227a6f92d848a6bbbbe9503e9e2e2a66e04920ed6492","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01785043?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-09-10","publishedAt":"2026-08-23","recordId":"NCT01785043","recordSha256":"86e22f3f1a28d8c64a400167f59d7f6f1457b1d4a83de227eeef41a2734370ea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01785043?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-09-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-09-14","publishedAt":"2026-08-23","recordId":"NCT01785043","recordSha256":"f70ee2d5dced32c3921f5dfe902049752b3a2933773331b9e0389544b0a443b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01785043?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e0c46a0915c56b3c173066fedf513934fd653f57241d246c6a86e33e45224640"}},"nct01899430":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01899430","recordId":"NCT01899430","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01899430-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01899430","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01899430"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-07-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-07-10","publishedAt":"2026-08-23","recordId":"NCT01899430","recordSha256":"c4920d063d2dc644954bc68324acceb958175112f19cb43035cef7b8d17b324b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01899430?a=1&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"339bc997493ccea3fa12842cb530f9d0821e333841ada27d0bb4f51ad1bc7b8a"}},"nct01911468":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01911468","recordId":"NCT01911468","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01911468-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct01911468","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct01911468"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-07-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2013-07-26","publishedAt":"2026-08-23","recordId":"NCT01911468","recordSha256":"776d09b793db7283ae156dc67bd83cbb0830ddac73b34d0d0776c5b20e6662f2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01911468?a=1&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b71bfe383761ce5810da87912fa283acf4c2963d8b4492dcb6bb66f5fedb59af"}},"nct02060383":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02060383","recordId":"NCT02060383","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02060383-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02060383","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02060383"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-02-11","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"93559cebbd5f3dd885d0f6f7a9d19d457c21457a85dcf34b728699c22c77f33b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-07-16","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"561dab10cdf8e4913c0fef9c63fcf9070f9d660e83b37fa54bfdc76338d129c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"0a55439c749e4d1cf7b5d5c4f130223c127876a98a7a48d66f8a28eb40b1544c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-06-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-06-05","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"8565343cf6781cde95109ec92b002f893abc1b9486699392398a4b1cfd0e0b1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-01-22","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"32a5d891ea899ea50dd983c3c3cab9c3159905a19783e08ccc89db7c803dd54c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-08-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-08-01","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"d953ed51cbe7f561438f17ed9efdc8e934e40a0bc5ff519a9e94ad2c3b3c2272","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-09-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-04","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"bb4fb20f391a62b02d0632bd57ce9cb5ccff4f27f9134fdec5c8e05e40e4952f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2016-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-07","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"5222c70abcd2310f55a5f3a0273005f6835dfeab740ea73e46814257af8b75e7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2016-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-09","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"64010fbba47c72012561f2d5ab5264181e23da8c740db665d4d1002424a4697a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2016-12-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-12","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"2299bbfcdb47c54fe8e166b17c9a0a7e4c0753222bb3386d4433a68d3e362d39","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-16","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"b317d1c6bd08b4d76eedbb9dd8f77b91533cfc322e8456b9d71b34e2405da898","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-02-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-24","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"8b475a55ab1bd0247e58a90b21c62f9941edb713ef828ad6134c79ca0451596d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-24","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"a60764efe0e13426d82ef16e8adf6aadd923c779ca480fea25d6d020e573a425","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Oversight","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2017-05-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-26","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"4c2e3c19e1c3f10763def28a1d000186b49c0c74efff916f4eaa274b3dbc76bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2017-06-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-06-13","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"55207f94eef37ab720279fb59a7b900d69cbe66f133f63d63009d3f31aef21d8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2017-07-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-07-05","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"4b4d1ff0ab7b4ea5a949ab1362899af93a8b08c5e4caab6b4a342e3982930e6c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2017-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-09-17","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"8e86dbf890622dc652d1e25fd1afb785a3f23e66b53f5bf013eca73a424260bb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2017-09-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-09-26","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"15653510481e870b479ab313e3148fd818dccce0908a27c9f8689ce3a0c9111c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2017-10-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-10-12","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"2afc9913130c011d571ef21eeac925e80c130fedf337f2a1816fc75678e502d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2017-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-10-30","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"2043b351c7dcd5224cb744d050017004918e53f855fd7543d0ef5929c53e75c0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2017-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-15","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"aa98959651e4d30f84ec03fe20f66b889ab4dba3050d2e26fcd0a9a6f15af1bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2018-01-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-01-15","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"a29f149ad1264088ee81d5b518834bd894c4ac6764979b9de3130fc7640d7b4a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2018-01-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-01-31","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"ca3924dbf71575ceef2228d603a103fc16c5c9eb6ea39768da3aedb590d52e9a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2018-07-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-07-19","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"9186f5982df74a310e739d15bbe557d8e28b7983dcc2403a21763fe08d448827","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2018-10-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-10-19","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"56268b65b7f8ba26afc4739070a246e59a4e6782d8e3c8a228b1ce1bef5e9028","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2018-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-10-30","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"f7b0bf5eb7301bda06c85fd83dfb360fc4b1d4c4d2bbbad9f0c2e469b9a1c4d7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Contacts/Locations","Document Section","IPDSharing","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Design","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2019-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-05-07","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"1b2265a6225c1431e0080191117db58bacc82a20f51414ec377f90f4c56aa7fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=28&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"053d7fc1ca54315af7be76fef13c8b05be022e989682728545f8901faccfd6b7"}},"nct02140983":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02140983","recordId":"NCT02140983","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02140983-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02140983","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02140983"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-05-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-05-14","publishedAt":"2026-08-23","recordId":"NCT02140983","recordSha256":"9e2fb894e882baea408984d8d051ffb007187e015a23ceeb0d01bcbe02942a55","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02140983?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-11-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-11-17","publishedAt":"2026-08-23","recordId":"NCT02140983","recordSha256":"196809047c762f11c614fcd6dc495215f020fde6f2da68d1dc84375743ef6fe4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02140983?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-04-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-19","publishedAt":"2026-08-23","recordId":"NCT02140983","recordSha256":"42faa58f043b85fb9c742e167f7613bc38d954b5c7fb807ad861c60edebc939a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02140983?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-10-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-10-03","publishedAt":"2026-08-23","recordId":"NCT02140983","recordSha256":"24cf11ca57e318c1c77ddcdcb895be5920d2b4fd50792555fc4fa1485f5bf96d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02140983?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-01-23","publishedAt":"2026-08-23","recordId":"NCT02140983","recordSha256":"d0beb81bfa8d5e2e01ddacd00ba3bde8bca6ad77a146ba5cc619d3d5cc86e1b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02140983?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1413eb0e1ef3d390ce341adc30c79198361b865808fa7056182531bdce470194"}},"nct02315001":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02315001","recordId":"NCT02315001","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02315001-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02315001","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02315001"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-12-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-12-09","publishedAt":"2026-08-23","recordId":"NCT02315001","recordSha256":"45eb0d1462fa75efe44f2f2a05e7e5940915d92ba739b335df318e36dabd50c6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02315001?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02315001","recordSha256":"a3c74afe818ddffa8eaeef6101302cbc1479cda857c0332c8715355d0974d81c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02315001?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-05-19","publishedAt":"2026-08-23","recordId":"NCT02315001","recordSha256":"c3c8b23bbdf57f61fab8f2a12b7ee56b3fbc9d7f2df9ee649942ea897c1e9d2b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02315001?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"a4ae50dfc2d4022994b1ff4ef743e41f517aae7d5f673528e982c0ad8152d18e"}},"nct02321878":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02321878","recordId":"NCT02321878","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02321878-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02321878","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02321878"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-12-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2014-12-17","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"981c720a732c19c1fd4f8a811676ae0872792d911ec4e23ba5c8864d68b351d1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2015-05-20","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"a37084742098aa0aa1d1c70e105c39030f834548ae7fcf04094256e8aebf4fa9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-06-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2015-06-05","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"3a278fe80131eaceb63d54c0f42c35fb7147811b1e34f0eed37d4dc32ab14f90","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-11-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2015-11-04","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"7bf88b09eda5d803ecc58be9a5c60942278f00690347d979bf2b59eb2f1c8914","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-03-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2016-03-02","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"3dff2b0348708b3eeab9dcf8c73abfb11f7b8d4f8b07c9f26b9480dd4bebfe2b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-02-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-02-17","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"4ac465439ef9bfe4a240eb79eb4f614de0499b1b24f8d4d724375f8cc306bf37","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2017-06-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-06-22","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"96fdf2aafa32251a2bc44a14fccca8a0804271cdab443abac9ad376b3cc9d6df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-08-31","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"10ea46dfb0622f35724c4ae71ee0e809556b0c2dbf8ff3f22da06ca084dbe09f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=8&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"74e94422df76e0c82f9a7bead02fa646c0e457b15daa237cb4f3d03cb7b645e9"}},"nct02351232":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02351232","recordId":"NCT02351232","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02351232-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02351232","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02351232"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"1d517974671b067b5f1510bf85a1bb491e85ceb08a5934b9bb23edf4806c7b26","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-02-10","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"c1921100e66b9b625da1ad7d1f8cea809aaa8c3dc5c753d0a9e4f72ff336a8a2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-02-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-02-24","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"ac75ac5ab48d503adeb27e2d4113bc81cb460eb6736897aea15370a59fd31607","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-03-03","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"b1790fb9da0bba98e01893eca405560e03975c235248626c948c781a4a4a786d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-05-19","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"b437c2051fee3f6e1a2f7536116f2d5eb4f7e5edf1a6b81cade066c2c389bc16","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-10-20","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"fd4de7a40a38b70390ec79b1aca962c4a2cd29f32e52ff269155f43be1fda984","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-02-10","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"72f4bcae7e76f8dd47200c7dc9aded8687d2834c2161a74a49b1528fd94b4e34","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"9e6f214966facf8fb59ed97949981ce37c130b93c98cf4a17870aee730ff0147"}},"nct02403284":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02403284","recordId":"NCT02403284","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02403284-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02403284","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02403284"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-03-25","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"0bb3b8fd99c31e5c0142509a9e3bc3b421c9e378d7732e6e125e1f4065ea6dc0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-27","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"4a30bf951e4fc537991c950b878d22de6b137e08ffd6199621ba426190f9ae3d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Description","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-31","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"b7506c303d24e78eb73887efeedc674ac1b479d4a910b0967906269d4d8636f5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-06-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-06-28","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"3c5d04f3fa3b51d1e9b5768dfb430a14a52d497cc0d1a2441dac046fa958d4d1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-04-03","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"bd641d5fde2bff5a3119a8b327158d6923ce79541d1b87a4d3ac23340b63c223","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-04-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-11","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"f2856d9f29b5f2b2fb1ae62a8dc8f5a25333f9b7f7fc7a55ee32a45cf6c156ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-07-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-31","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"275e4ca579e20856218fa84e30c52103c34526bc4618c915150d026e64c80546","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-03-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-03-11","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"8f718f26d354f73501741dc4bf4d47b295135f70f54dc1ecf9f00a65040c71b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Identification","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2024-07-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-07-18","publishedAt":"2026-08-23","recordId":"NCT02403284","recordSha256":"cfa8ad5a3eda5bd1f70f75770320723da61bccc06121ea461cb33f7bda8ba9a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02403284?a=9&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"32533e5be9e99b8cfc845eca5fb582eab4c906761efb03dd5635b48e2d18e993"}},"nct02473809":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02473809","recordId":"NCT02473809","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02473809-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02473809","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02473809"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-06-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-06-12","publishedAt":"2026-08-23","recordId":"NCT02473809","recordSha256":"ef3905c0bd2995553c20276440b6d6aa660ec4facd7edfa09c82c6e57c5d490c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02473809?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-11-13","publishedAt":"2026-08-23","recordId":"NCT02473809","recordSha256":"454fddf9023106c789014f236bd3fe02743692f5151ea3fbef84360f1ef60a05","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02473809?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-10-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-27","publishedAt":"2026-08-23","recordId":"NCT02473809","recordSha256":"7cdaf618cc59d0d12737f3149b49f591e95b2696ebc1db1988a1bcf9e62590e4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02473809?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-09-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-09-25","publishedAt":"2026-08-23","recordId":"NCT02473809","recordSha256":"48c3bf2c3d4b6101ca4a5d7df05dfabc836d841d64109948cf0d09ea0aefb1da","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02473809?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ac1d0193fb7535f9b0d4745fde1ab562bc39ce1c0bc7928cbff0dc62c64289d8"}},"nct02488057":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02488057","recordId":"NCT02488057","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02488057-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02488057","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02488057"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-07-01","publishedAt":"2026-08-23","recordId":"NCT02488057","recordSha256":"2418955e394a690756ebee0c2e23ace44c149888b32f91a33c9303a8e6d21785","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02488057?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-07-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-07-07","publishedAt":"2026-08-23","recordId":"NCT02488057","recordSha256":"72869b57feb7afcaa7654f78e9d2f360c5343f944f95f358b68e19c995a658d0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02488057?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Conditions","Contacts/Locations","IPDSharing","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-27","publishedAt":"2026-08-23","recordId":"NCT02488057","recordSha256":"61419d21bb26225e2757140e2ed27e8cc2bbfe9e1d1d6364765613eac12c77be","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02488057?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Eligibility","Sponsor/Collaborators","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-05","publishedAt":"2026-08-23","recordId":"NCT02488057","recordSha256":"2c242d8dc65b9b110e5a89e1366e2b5fba75429105386af82bd6a6161783607f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02488057?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-04-03","publishedAt":"2026-08-23","recordId":"NCT02488057","recordSha256":"114a8c58067ab423247c50d0e18b440b729dbfe3d459d3ef2708a5cf74b0e64e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02488057?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"48caff1ecb8779f79910a3d2c38cb86cc03d9cbb11fb93d21d3d52ab20d9c306"}},"nct02527200":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02527200","recordId":"NCT02527200","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02527200-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02527200","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02527200"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-08-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-08-17","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"814f516422e6a55eaa2edf5734404b05dcd61f0edc175bc8acb21dab4460b466","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-08-31","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"a5bdfe24c34fdb346fa8cc44c5b01d6293b9bc8f7856962c69855d87c0fcc210","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-10-06","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"9713317f144d331e70baebb9fdd44efbdfcd20f7ed52f422bd4d9ebbf6a7980e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-11-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-11-11","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"dd55acd8affd2984ee35d1b34e9d397e3ca37decc0a4e89b793b139ce5c1dba7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-04-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-12","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"4479a9baa7e86eeb28b19f7b060df613f3762a2cdecf996054e45ad2299f7c54","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-08-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-08-18","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"5e597945e2411e538880cb04f6c720ed5b05eb604e6d1fb394f57717139e5c81","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-09","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"598f16a819e3726d26766c104c5678c9a388034ba18f4140912a41c8f73cb585","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2016-12-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-27","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"0e6125064e089eaea776b4de35a1f8b1fb6755fc7c801374544df1cbc3e4db9e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-03-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-16","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"c48cc004cffa872c78481f2493af0a33739e089aea56e67b61dd6c2213aa3477","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-03-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-23","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"ebb9b6e248f1eeba12ca3bd5fd96ce26dc4128e8fe595bcf90718ce6bc60141f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-03-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-28","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"a17ec01d540d8034067d414f08a55a65c6dac6eadf2c22ac3d01035003acec47","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Oversight","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-27","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"bf6c61d5c0bda739ecf8387c20fa9318fd58d44feafbcf222df67b0e74e05754","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-03","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"0482108b1a85ba80e0e48e198868f3efc8468fde2a5bda421d0dbe44a85d62ec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2017-05-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-29","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"05e85e4e0dee5ea4aa2869740b3eb14e97c358123640fbb3c75c7d349d023d96","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2017-06-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-06-29","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"d8d439a2cc733d59ce2e0023b8a95790c461ce1c185cffc13809f4187523b410","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2017-07-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-07-25","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"2139dfff941c198a8d003bc116cf6954e199744043b638a7c352656c56eee331","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2017-08-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-08-21","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"09c5574a1b0c4b4097d752d743b727ba57fa925402e284c981103a85a9ddbb1e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2017-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-09-28","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"d7d35570449925c77e46f1f42ac9cd8fd88985028e78826506bfb27fdaaacc1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2017-11-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-27","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"b7c7568edb93737852be3f8d4ff81fc94113e2464ec04d209c166700f73bf48c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2018-04-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-04-18","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"033d27d20e1a7f9b983b4e9003c7ace118c96a229077e0bc975293a57f1a94ec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2018-05-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-05-30","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"803187e270890d2a19c48f6a7e5d9d7e0fae46a5b1cdb93d42e46d4d85221d5d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2018-10-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-10-01","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"af3b3007eb10b083238ebcc3854a1e8a9aad92de6fefee8987a64a797a9d2045","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2019-09-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-09-11","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"4beffbc14ff3d6b10cb4ae61d8ff82f46d3168c35c386cf95f330d72addf25ea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2019-09-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-09-30","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"a3fb31a46326419db1dbd7e8e84e8e320d2b0717b8987713886af834d27e0acf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2019-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-10-07","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"f8c0156f985316d1f839192f4e116961d4062cff6fecb5da4e8680d900088781","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2019-10-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-10-09","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"d63b6800c0e64730c6599951a9823cb9d961bc3c65723bad721a00b2b24b288b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2019-11-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-11-12","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"002bda140115b48b62c4c2846d3673ada697914566301b6af49a225ca14aa198","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2019-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-11-18","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"b73d9b98c7d7a7d27e5da873812a231c6efb8ea54d0293f1d3ba00882e6a7d4f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2019-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-11-25","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"2041a290c102a5cb6663fca44df393e14edb84ded5cf948857bd479f42c289b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2019-11-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-11-29","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"d795b9d7cd03e387e71c29ec2c35099423fe3b8511daeccb4e9b3b94eae0e386","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=30&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":31,"lastUpdateSubmitQcDate":"2019-12-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-12-03","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"52a86cc3df3aa14157fbf0b0a2d7f70e3cb49e61c1efd17e71c9179b83dc817a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=31&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":32,"lastUpdateSubmitQcDate":"2020-01-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-01-20","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"2b5ac320f8266dda7914797a416cf6380022c17a23555eba57186cd39913eaf1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=32&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":33,"lastUpdateSubmitQcDate":"2020-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-03-30","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"7b79c07768566ad16b8ff90a4ceb022ba7816b3897dc2d317bf1c26894dd4b03","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=33&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":34,"lastUpdateSubmitQcDate":"2020-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-04-15","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"e83816e1af95ddb5056edf2c446e7e738a3a51331caadd8cb58c44c127647693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=34&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":35,"lastUpdateSubmitQcDate":"2020-06-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-06-25","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"2dc9834fc8046bfd4fb9bbbb5220f11016f1185abfca97d29ff1ebfd11487ebb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=35&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":36,"lastUpdateSubmitQcDate":"2020-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-08-31","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"0a5e90f8dfbea5c78b664b0fefc8f78978dd8e204d11ebe692936a82ee3762c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=36&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":37,"lastUpdateSubmitQcDate":"2020-10-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-10-29","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"37bfdb7c624e67af83a62a75566245db29452db012ba5f9b2cb0a1fb6757f25e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=37&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":38,"lastUpdateSubmitQcDate":"2020-11-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-11-04","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"e3f57311afbd2bd9c0bf7e233804a56693d684836f940ab718fdea45f73d36f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=38&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":39,"lastUpdateSubmitQcDate":"2020-11-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-11-17","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"890e24f077b49edc024d3e7d92747b06d24b2c35919eeebbaca99ed446829443","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=39&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":40,"lastUpdateSubmitQcDate":"2020-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-11-18","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"5cdfa5ce77700783be0907f598ec3f00794fd0d0de9198cd67a2e5248f34b53a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=40&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":41,"lastUpdateSubmitQcDate":"2020-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-11-25","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"683456949805b9c3f81edb81ad5a9a9bb950df61729164fca7b1c26afa53fd5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=41&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":42,"lastUpdateSubmitQcDate":"2020-12-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-12-02","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"e1040e7fd4dbde289e01f7b25f92827082a62eeebf1a37d2faaf3be48a10d31a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=42&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":43,"lastUpdateSubmitQcDate":"2020-12-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-12-14","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"5389f3d7d64b4d898be7f51ca15f9779e38c62f1d82732710044238c8b219cb8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=43&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":44,"lastUpdateSubmitQcDate":"2021-01-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2021-01-13","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"5062e7e3eaca31607522a8ce997fa40bd73dfa7b8fd99baad571073e13bd43c3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=44&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":46,"lastUpdateSubmitQcDate":"2022-02-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-02-02","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"993626d4d2b973540b3fbe14e32e83ca1616e421fbe28b608e64994590ccdea5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=46&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":47,"lastUpdateSubmitQcDate":"2022-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-11-18","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"a73d71bfa914ce1a2d82364e4f9dec5c6d5e0c4702fbcd07e476e58cde5b4921","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=47&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":48,"lastUpdateSubmitQcDate":"2023-07-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-07-05","publishedAt":"2026-08-23","recordId":"NCT02527200","recordSha256":"e9182f9188955ecbfa7c0aab388919822457d861d93b1cf27521f9dbdba43d0c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02527200?a=48&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d7eac2bf6a627664b664b4ec4d3b7f69496c82274cc7da98e24d689199df180f"}},"nct02545738":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02545738","recordId":"NCT02545738","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02545738-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02545738","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02545738"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-09-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-09-07","publishedAt":"2026-08-23","recordId":"NCT02545738","recordSha256":"c60bb685d76f656aff4d34a0565dcc47bb296c4802890031705bc92b658eca89","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02545738?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-08-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-08-09","publishedAt":"2026-08-23","recordId":"NCT02545738","recordSha256":"ee06c09795285eb769c5c77d7a99b2d933368760f7efc20e973e2309ef17ced7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02545738?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"4e939e343b354e2ce5dc8a8b44be462e7a442a3280ebc112b863665376257242"}},"nct02616003":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02616003","recordId":"NCT02616003","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02616003-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02616003","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02616003"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-11-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-11-24","publishedAt":"2026-08-23","recordId":"NCT02616003","recordSha256":"fa3059264efcd9587a6c5da27c7d4c34c72da73459e70a37a44843683e78c6a8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02616003?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-10-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-29","publishedAt":"2026-08-23","recordId":"NCT02616003","recordSha256":"9e20068b0293614fc32366f2dd15a304dc69a1f67d1e66740e2d1406e5e29b31","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02616003?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-04-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-24","publishedAt":"2026-08-23","recordId":"NCT02616003","recordSha256":"72dc0bdf1cbf5d5bdb96537fde6c1789e07066144538f20e0621052b75ca7278","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02616003?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-04-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-04-24","publishedAt":"2026-08-23","recordId":"NCT02616003","recordSha256":"6ba90001920c280e2248971a86db3b3944a92870986345d5403421c561c38ceb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02616003?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Description","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2021-03-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2021-03-21","publishedAt":"2026-08-23","recordId":"NCT02616003","recordSha256":"85b315505f69f376f67f691ad95003c9018a48bd94b4b13f5c866e33ba9fdfac","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02616003?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"2b3849436a356e3976724685c5574ece382c2b6b886a1c38af53ea955b4adf79"}},"nct02647944":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02647944","recordId":"NCT02647944","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02647944-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02647944","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02647944"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-01-05","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"ce3a23e4791aa7575b4ccc668e87d84fbbd7b4928ea0c627e44312cd9258dc20","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-09-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-12","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"880b043e9c83fca4293bcb44f7f290e69b956a9a99ffc134900a0e261738de32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-03-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-21","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"62f9b98a4211003a72f6e662d5d502cc0b2f228df78a72bb61bef3f14cd7644e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Oversight","Participant Flow","References","Sponsor/Collaborators","Study Description","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"81b2072303f80a418184aadd33b2cd79b0e9fad48102a6dbad34cc58c01bdcd0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d337959bd640e5e30e136f88dd3546a4d94091b7fe8d2f7b93104937ca92243d"}},"nct02650206":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02650206","recordId":"NCT02650206","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02650206-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02650206","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02650206"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-01-07","publishedAt":"2026-08-23","recordId":"NCT02650206","recordSha256":"c0aa4d314530585ee78dacb1beb0149b13de0fd5e254b140382d2cacd3bb57b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02650206?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-02-11","publishedAt":"2026-08-23","recordId":"NCT02650206","recordSha256":"9e0328b5c9b917ee390f5c04816a8db1187975ad2316d64147453d8412ce2ba2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02650206?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-06-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-06-06","publishedAt":"2026-08-23","recordId":"NCT02650206","recordSha256":"2d666945de467f2eb8560f65d937755227666f1162cc4bf5d43547e996fbf928","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02650206?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"99678466baf49e3c72f120a75fcb196fe4e52451916bb041454fae64af2e380f"}},"nct02717858":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02717858","recordId":"NCT02717858","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02717858-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02717858","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02717858"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-03-18","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"180ab09fa2086480d688ec33b8b8e3a16d1ee0094e6e7429959c5d40526dd0b6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-04-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-04","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"0683e8101b82762ad682d9510719a8fbba59915aa897818c8f2cbb73f91f8794","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-11-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-16","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"5920617e630037ad1adc18df75dddca7921b03462cfaf740b1edb63749e5132c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-12-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-08","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"d55dc4996439e04efd081465f316a2b4ac6d395b4bf9f70b6547c7d2f558b74c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-03-03","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"b301fa373d455740b2737e9a034397ee46f4b71ddeb72cf5ee1e8405a3bf3438","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-07-24","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"94781cd37f5d449100a94411473ebf904bf665e4255a498d69bd31faee566cef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2018-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-06-26","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"3612eb457a16b571f8fa86b7425cf2f36aed41490c33bb7a3111be0dedeb0996","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"18b512259db9a13cd0b8b5904b873d4dc8ba8219dc5b249759e5550feea96a59"}},"nct02765399":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02765399","recordId":"NCT02765399","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02765399-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02765399","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02765399"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-05-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-05-05","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"a04869dfbd9dedf7a31f85b031299f7b8da46dbe8123d8b05a6381b339f8dbe1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-02-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-28","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"de51d0d9b2c0c8146e21f9991cffadcbd5eb71b6142f56b0c08823ed42260975","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-01-24","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"89a5ad5dc4b1815a0c5ed21d9625d7d0ec44296a9962a0a32b47ca442f506693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-04-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-04-11","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"5902fa62b5a86b5b62f95166243dee796c4b342de55c9c31f8e694961a6cbfd4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"464de1a606f80c39d1cc7558b083e3daa581b9947ec8f1d5876ecd9037941c15"}},"nct02911818":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02911818","recordId":"NCT02911818","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02911818-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02911818","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02911818"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-09-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-20","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"9cc8318c4df675baec64926b4152ab50b8b19b402b8474e02e6d1a26de3df9f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-24","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"63b501a5818b3ab2039d86fcf309329b4bc453e9b100762d3de3e3fd259a7a3d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-11-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-22","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"53dba08557183a5da4c92896736b2a4b5d98485400263bf25a67ed5a4b88376e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-08-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-07","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"177c473784a9cbc2c0ded41cae85afbaebcdb681287128da4bc572ec90b3871e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-08-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-07","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"0bbbeba751743b55865bc8839aa1dd6fabdd7ebe33c65b94b5f24e46c879c454","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2018-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-09-10","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"83993ee34ecebaf502202ec6db883382835974db0f1c92c2cf27d32583a6afd5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2019-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-04-15","publishedAt":"2026-08-23","recordId":"NCT02911818","recordSha256":"ab7797206e381471ba36c0dc9e03ecef30529ed259026b477f441e4aec911591","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02911818?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"74bdc4a4f486acf94d84b75dddddaf148adb1d6e8bfaaeea02f23851443e99aa"}},"nct02918279":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02918279","recordId":"NCT02918279","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02918279-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02918279","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02918279"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-27","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"0c880ebd4c98fbaf57c4b3a44e0aa72c5904097dc51d0eeba8022271ea9ce401","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-06","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"679b6e7d2c3293cabf103f034db4f1e89f402b1ffdfbb0f22c39c8d39d3352ec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-20","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"7dd127e84aa0c0178f6e28a654a8601306c0a0e3be6f6f1094c7bb8466445ba0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-25","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"d90d5bb83b04e4c7a53f188714847b0382091ac21fc61175994baea1596d4b96","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-11-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-29","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"9381f3942d0493dd8f2dd01a2109fc25f9ab4c9b90cc09224fe40674cdd9517e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-12-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-02","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"900877a53dd0ed21685591dfb8b5333a5b82528d6170fd293b069638570ad16f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-15","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6f463011db1eef0e93dac90a41d8215bce1af5b0ae994834df13a8a0dff442b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-06","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"c03cec56022def2f9a0977f51695d2e853683418ef32b17fcfebf0f486798aed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Identification","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-16","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"925b0f47a2d87645b8747310316d71d288f705d5e16270c394588ce7e22b57a3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-01-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-27","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"fe0867902809dc6181401301fb6f8618f9954b2b69f612b32f1f41d9e3ce362a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-02-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-03","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"11f9c0e6a82d8212a689786ab56ca2a33342e7b27a15c630acfe3e914f8406c3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-14","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"35113017cd35056890dc15077c2d07fb4aff8a0b327e3752b19cf33445899871","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-03","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"e856d79a93f4ddd5759cbe446b8444018bcf42244c9cb292cdd30a92fb20e05b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2017-03-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-17","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"da64a0d1cf224876307446247cc5a3a762ac3546e388825813f6b14e21512584","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2017-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-24","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6009a0a8e018f379db369bd2a60efb327afdb1f396097313801421006de776b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2017-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"13870ccfdc8f44add9bb1b736f4c046d2977aead9a59e30b0988f289afd92c1c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2017-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-27","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"cf7a23051c05b2b3968e86fc4dc7bef05a37a93772fef71eacd54fec6180fd3c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2017-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-19","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"7b928ab8b9a2c67cd298609a94dc03db8c27661dfea5d346d8b15111255deb44","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2017-06-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-06-07","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a7a92f26056ca9c14ad1159290b2527f92fe7329a223828290fddbd5ae28a840","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2017-08-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-08-18","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"ece59243f35834244549d13d76e56dc368c30a5f59dbde24990e83f61fc7a77b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"af9397e908fc559e9125c5aa9a184c7997e83cedf71a98f8186dfa60d7918c97","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2017-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-15","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6895d9cb98fe1126578e7f4692bdcfe1305d0c58a8da90f7c66e51af85a0a8af","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2018-07-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-07-11","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"c404540bcd66cd91b892747f64e6e53a7216cc24e61aa4e5537e1fa25cf68701","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2018-09-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-09-18","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"06982944e2cdf5fb5f2e4bf2825f8946c099c58b3cdc93b8198d165468bad3ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2018-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-11-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"d7e60bd3fe9234ed6581960fb20af2af791695a08942ea75092b12420d9bbbf8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2018-12-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-12-14","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"b9c84ed8c84a3222634e3fbca119f18fb6eee8260b0658911e95b80324274a61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2019-01-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-01-09","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"4a786c9d38f35ba63597ec7a30f44f5ac77808f8f10c48bca8fd10a2f371a0dd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2019-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-02-12","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"76e5b591725cc0ca67ef9e7c68701b162ad6bf61c1e04883abf6cf9fbb99ad44","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2019-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-14","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"280146200b52852466ab6d1ae0e31fdde46a51d5519481d5415deebf1c4ff0fd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2019-04-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-04","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a35b2221a2294f98974491317313162be28193e00a562954024aa46650cd7891","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=30&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":31,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6cd566a77ea0ddfc6bdd7602e91bfcc8645276f9cbbb2a48cfb91d320e9fd771","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=31&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":32,"lastUpdateSubmitQcDate":"2019-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-06-19","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"554b41da92d3d9e5e9a9c884ca03bbfcfd427e08a8cb99444146190f6a66577c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=32&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":33,"lastUpdateSubmitQcDate":"2019-07-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"7c1bd351e2be4bb8add4827d26fc6e327a54cb6e8717392df5f044fbb5012b9a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=33&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":34,"lastUpdateSubmitQcDate":"2019-07-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-10","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"b280384e4a9bb4a19948e419dc2bcbe8034dfa2ef42e665b733b6a38b14d70ef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=34&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":35,"lastUpdateSubmitQcDate":"2019-07-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-23","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"0d38db2c90ff81f688de2465f58d91ec0ed08da3943e1857dd6003916b8e6099","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=35&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":36,"lastUpdateSubmitQcDate":"2019-08-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-08-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a60c977f80c08eec74c1117bb63adf599deada03c56ab8d993d34643a73cc698","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=36&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":37,"lastUpdateSubmitQcDate":"2019-08-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-08-12","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a39e892cdf954b392dcc700bd03dc806dfd45adb0b1cb7d232c20c63519ae32a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=37&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":38,"lastUpdateSubmitQcDate":"2019-08-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-08-20","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"4ab2eca89503f90b837fb743e74300ae5141b886df2247c5eb3f1688f5ec21aa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=38&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Status"],"historyVersion":40,"lastUpdateSubmitQcDate":"2020-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-04-15","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"d05ba2c7593b147611ec6c93d5023230d2c8bcdf6c023210b50777065de77e32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=40&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ea9f8611c19c81435a199770fcf23386a58326bf67619d1c38ec6df106327d89"}},"nct02944500":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02944500","recordId":"NCT02944500","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02944500-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02944500","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02944500"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-10-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-24","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"9fa7f12cf6f68bedb56584dcdf652f6f2af9827fb8a69fb40eb7c4eb7ef77891","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-15","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"8ce4e4247234293514af40fb718c1126e9bb1a5047fc6655f839761175e16b4e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-05","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"3c8130e248f68f3401849fbef833b75734b65f8f0b8c6f4236fc5a3d1b813d34","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-01-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-25","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"400a5d877be1b315ebafb12f4b2ad3a85c7390c6406ac4d9a251db14951c7519","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-02-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-02-16","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"c0732814bc52d8f90b5d53bdad7f88c0dab524f943ee253be2389276bfab3f9d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-01-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-01-25","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"7b19ae727096cf4d59d2756252ca9fd139e4a0e22fa2d6daf3f27fa8a7da3e67","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-05","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"cd8946530f90969dea8727bd6a5a2cca1c682fcdda002d971686478346d502b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-06-24","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"9bb3865794f0c0ad6c404c8e197b91b3b0332976cfda893e147d0ef7a846d44e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-01-19","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"81e09467c55aa92a3d628b104f5767ad336b131eb5e018d13203644e8788c77f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2022-07-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-18","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"3802fa5a2c6c09db1ff15b7592e3d255b3e257fcea7ca8a1bec1bc6b558d5aec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-08-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-08-09","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"90bd7b9e56213e9b8d89734be2c1d99827a1e191423c6ff6996247b1059e651b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-09-27","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"d702f09d8d3d8b37c958678db1bc049b4ee4126cb268d8b66b27c85de541b2b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-03-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-03-19","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"ae12c1f19f2997337199fdf9db29ba38602f3a363589ca04cd04d49c2389b127","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2026-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-04-27","publishedAt":"2026-08-23","recordId":"NCT02944500","recordSha256":"14d8d414a444d5581f78d38eb3659010651a288efc61ed177521358e83ab5953","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02944500?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"c4201e6d98e95f7d3d69c9a349bc51243342e6897f2cc07fa0c87d977bcb71b1"}},"nct02953665":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02953665","recordId":"NCT02953665","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02953665-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02953665","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02953665"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-11-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-01","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"d9b82866bc569a5f7825824c4deb90b5aa85f1a16d21a4034d9292ff12058eed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-03-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-31","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"798affac81e773280447c480724b90345ab2aec5ae43ed27d19d3c7de90d9cb3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-04-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-11","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"6a5e7181392b63ebe49f9ce571a73558977c7345513c19eed592101d1d8e6843","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-04-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-04-12","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"dd8d7a0a637a5277af717a92781bf9b295d0b6df372802ae8dbd7e0e3080bac0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-05-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-05-01","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"24f42ac7b9e6bd826e3b2fab4654240bfc034401cbef37b15703235e3a570e4b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2020-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-05-07","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"90ab78c94cef0f53188dcb83aef135adb4edc1417d2302b752b82cafb2fa1eee","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-10-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-10-22","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"6cb172a6d06908acfa8ced252f40e214051881b69915d37bbf1937f0c6f2f49b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2021-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-20","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"c498410fd5f10ef6724f6a0480603198799391c82d6064d17839779165c8e365","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2022-10-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-10-27","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"ba6e3fd904bfb1d3fc94ab767dd7480227a3320fc7e937852635a2b1fd0a9a13","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-03-04","publishedAt":"2026-08-23","recordId":"NCT02953665","recordSha256":"2b7e9db294032c74fa2a1ebb8b4d313131eed23bc7e8686d9cd677c5d4716467","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02953665?a=12&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"56af00b74137518292a61db26201915fceab862534a827752bf7527cdeb9a80f"}},"nct02967757":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02967757","recordId":"NCT02967757","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02967757-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct02967757","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct02967757"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-11-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-16","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"63f3f895976deb76094a3c5e0c7d5bbf5bd40f5b7852656849db77ca2c860a45","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-18","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"8bddc372618246d882ae3cb9c2328dc885cbb4045230743322cd5b919d921f44","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-12-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2016-12-06","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"afb3d06221bf89e711dc98fc49cb2d1082a5c3c06201bf089d871ec9c6e20c7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-12-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2016-12-27","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"18ae0a4694b82be350df624aa2012a216740cd5103b63de490a969a8115e8729","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-03-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-03-29","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"b9f23c1cb528b8809f23ff332960bfd26f43e6b8ecc5fa9fea114fc5a324f43e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-05-11","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"0ac31c1643586213a9a03b12433601f79f0e963c851d3df9530829a766aa5596","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2017-06-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-06-22","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"c9946846ca03f6cc6582abd7ed62e5338b7782e5c25a0ef6aa65536c4d299cc5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-06-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-06-29","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"efebbc8dbd100844f1e3a4f88f98747ef39f256fa8a75f3228f55baa767cc0ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=8&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-07-24","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"1101420ad3524e425a9fce2ac37f1cd7f6747eb42cab2bd8d3c34dba2e8fb4f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=9&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-28","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"500fa8c3619f3c078a69a6998a2863a6b5c413df4b60a7c166484e95a34b23aa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=10&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-10-10","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"6aee311ff05572216fa05901f78eef1aa374d0102bf337079d6fcb1afcfb1803","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=11&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"9fa834e3ab1d22af7a3f1b1061156f3854f141d8ea128ae1f2071e6d09244f41","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=12&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2018-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-03-12","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"52253c1ff8d3a038564365c9e450e2fcebf867434bac6019e20c5b44463ee308","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=13&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2018-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-07-12","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"1dab98eba980100d0c28f6b5e17341df5312e4c52bc4d86a485c4c8dadcbc281","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=14&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Design","Study Identification","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2018-09-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-09-14","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"a950e7ce3991b23a25f664da56d2e2dea7afe012195b64cac6cf76b56f02ee14","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=15&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2018-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-11-13","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"c3fb82e583ce8297454df3ac1eb7b34980e3a950108df112470d511b1572a61b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=16&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2018-11-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-11-20","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"3ef9b6552470df3fef6f9e29ae04ffa0b4ed81a1ee3eb408544e552b273b7cd5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=17&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2019-01-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2019-01-17","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"4eb50c4fc3cecb08428cc096b9b7123a4a69597ca4812354b55fed16f9307212","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=18&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2019-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2019-02-04","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"9a5385338c5b4713cf9085735056500ccb15ec6ef07885eb190ccbc75595610e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=19&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2019-07-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-07-03","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"da2c5365b9cc7a2d8fb5f0c7cb5a34c32b7464f4445ab028a5855823079ffd5d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=20&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2019-08-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-08-02","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"62a4bbb0b7f68eb622633a5279705c6ae80c36b24cb1ab9c32d7d8e4f24fd20d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=21&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["References","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2023-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-01-19","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"8ba256cf5a638144baa9f37410e797b01c758488a4d5dde17abab84d0a0361fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=22&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"49176771bc5f9274b10d977864e494ba927b3fe4588a46bc4bbaa64be48271a9"}},"nct03036800":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03036800","recordId":"NCT03036800","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03036800-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03036800","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03036800"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-01-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-25","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"29c2e57ff3e4aef6eda75f76373772c3f5cec033cb8b93da135d5ccb0dc785bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-25","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"321fd3d915ad31c80fa6fe635a78c7e216661a8b4a9b1ba5a912b8f18c8605fd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-07-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-07-25","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"e9a2d28b25db6e97855397c79067f64868d2a6cbe4468653c3d0e6d49d78e7ac","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"WITHDRAWN","peptideSlug":"liraglutide","submittedDate":"2018-05-03","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"78dd6231141d510e43241b87219312ef799771e4356db92cff28144608090925","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-06-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-06-14","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"30897896d6ece7348e8a960ddb7e6eade865ca7b00a1f19206cb11cb57122535","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-12-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-12-12","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"8905f711517833f13ce7262d287bf28d5667a8006224718358d5e68aedd87c56","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-01-29","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"51c9006379e73155c616c73c0b00a57218f36d1c466083353ec34189fd403c78","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2021-01-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-01-13","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"736206fd2a5fb463b111470d5a69ffbdedd7b42286fb59fbb909b64f2d2073e8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2024-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-03-04","publishedAt":"2026-08-23","recordId":"NCT03036800","recordSha256":"780d1c79b6593c9df13169f37d11b45b432d9c17f8be9eb8f919a2cbf5395995","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03036800?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"5456a95254b7fd796c5362d0eb13ec2b7623d1088a614f2065420b8cabbe9bd4"}},"nct03068065":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03068065","recordId":"NCT03068065","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03068065-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03068065","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03068065"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-02-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-28","publishedAt":"2026-08-23","recordId":"NCT03068065","recordSha256":"ddf14b24576fdcc11b5fc001ec7504384fc89e462922712619561477ccb724fa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03068065?a=1&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b59000f96d6f1d1b385cbd8b9e996fefda6a1dbb6162eeee92866979a33951a2"}},"nct03158805":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03158805","recordId":"NCT03158805","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03158805-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03158805","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03158805"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-16","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"59a8f0b8feb6f5bde748d136ef21c14426a682337a1bb1bf804e23c6107765ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-08-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-07","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"acb2f85f8b51f3cc7899758ed85fcc04669520a98efb402e57d97c51ce9576da","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-25","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"27cc490297f77c983e9fe84e4202afc5ada6f48afe4a4865d2d746224ce75a17","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-08-31","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"e0f82372d4543d84f45beeca6481247d28bb6fae942c535da7ff0612626c8160","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-05-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-24","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"d36e6f7f2b038209fc6e6fe031fb9a302d1054026b3d4ec9e1bb25d3a6e66b89","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2023-03-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-03-07","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"d5ee512d3565ccca73d647ac52855f036bb7bdc7a48edb34bcb1815d4ef0a3e6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2023-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-10-05","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"0b98e8e1c50d99024c0abe301e0e5674d68ff7089b8f3dd89d5523636e2a853a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Outcome Measures (Results)","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2024-03-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-03-01","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"7e0e8a4feacfe6ec7d3c01870b3c3ae67d3c5665c5d25c25b24fad7654f77ffe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Limitations and Caveats","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2025-03-03","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"c485ca22c441451ceb2b497cc2c1a4395c104d5662280f1578fe7ea7aff340f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"2349ccd6ac84c0436e05d33be8e2a8c395722be1efc4759dd967353dfc5b9c03"}},"nct03374956":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03374956","recordId":"NCT03374956","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03374956-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03374956","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03374956"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-12-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-12-11","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"94af95c163d0c884a0217a9442241aa39860fe8e57f879f506ae9539539bce8f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-08","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"6ad5fa35562b1da8420ac20abb99692faeac6cf31a62c318f842cfbed341a9cd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-05-04","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"b08a4e452672c07ea28f3a83a9dd9449ea049ef612374efaf99ab73fd596c817","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2021-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-01-05","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"007aa410442f534b171a71a0c6b0b17146a62bd0e4606e9bc04a9a2fa29935e2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2021-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-05","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"2ac1f6a17f7fc93711f840b8a5d25f67dc937cbac44c1e4ecb6ce0e81d55a389","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2022-07-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-19","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"7e957e362c4e239c10783736562db3782838f3f9bc9d27f750a00d6fd63df1c0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2023-02-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-02-02","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"df9e190b014416caaa6a1f8c8e86c73270de1a414a692736c2eb472e0bc34f3d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2023-06-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-06-27","publishedAt":"2026-08-23","recordId":"NCT03374956","recordSha256":"db121e957d513d83f60b77143905795b9ca3fe1477cfa27039692a55c5f947f6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03374956?a=9&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b8a4ab93d3886c89a5ce243a17ae8d6c2d20b79f7ec6c3961a24773fd666e952"}},"nct03466021":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03466021","recordId":"NCT03466021","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03466021-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03466021","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03466021"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-03-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-03-08","publishedAt":"2026-08-23","recordId":"NCT03466021","recordSha256":"144ffebdf650695ca0e35f02aaaeb274aaaef1f6b3a04a51f0827bbfc6275e41","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03466021?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-03-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-03-15","publishedAt":"2026-08-23","recordId":"NCT03466021","recordSha256":"44bc8ef3c8fcad6636bbb2153882182c554021221328e2e9c36db052d94448d6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03466021?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2021-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2021-03-12","publishedAt":"2026-08-23","recordId":"NCT03466021","recordSha256":"36cb6ed5d7d9ff67072857cbafa70f105032cfe295490e8077506c88b0924d06","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03466021?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"383365057e50d09591c96bec35a31c9fd8e3be2d02fe2bc558d043aaaa4e0652"}},"nct03479762":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03479762","recordId":"NCT03479762","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03479762-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03479762","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03479762"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-03-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-03-21","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"f0467fe97737110fa845d8f2716fdd8da556289f85a96270095ef1e8eda86f72","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-05-16","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"54e343dead28ce026d82ce9d3acceb6bdf96f7cbcce63f42a1abc5bf8a363c7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Conditions","Eligibility","IPDSharing","Outcome Measures","Oversight","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-27","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"c43c42aee73ab0390e14565097e77da280460869272bdf691d6d6149ef11f336","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-05","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"faad25a89d06ca3a29d1217ba2002d17ffc4fccea9276419d6d1f31bcf36cff7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2020-04-20","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"439d8d2ea6452c9bc37d2b5d034c767fd79e28e8722eedfecbdd03b0d74660ba","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2021-04-27","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"484e2fde97173c28a5ed426974b08f38b317d1c88c585fee2da393f8265637d2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-11-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-11-08","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"e03c2a198bdab1c7a98595f4aa580853e688c4739c1a6c53c67e135333e1f9cd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-11-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-11-23","publishedAt":"2026-08-23","recordId":"NCT03479762","recordSha256":"e20628a8ba0457f6220629ea04bbf61ae1619a8d479128311209bd3b890e563c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03479762?a=8&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8731c08842b25d8e5e2a1551e63aeeaa978fc9c54cabc45c8a3ca5dda93632bf"}},"nct03619330":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03619330","recordId":"NCT03619330","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03619330-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03619330","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03619330"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-08-06","publishedAt":"2026-08-23","recordId":"NCT03619330","recordSha256":"278be9cc77d101ac68d48084d6253b2accef7c81556b13e7e4f2ba09c57d56df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03619330?a=1&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ba3026bfd56b1489a1e22788093b48fee21353d2873a838b30be81c7c4459d4d"}},"nct03672812":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03672812","recordId":"NCT03672812","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03672812-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03672812","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03672812"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-09-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-09-13","publishedAt":"2026-08-23","recordId":"NCT03672812","recordSha256":"848e7e8511df2211572657a67f171e418e34f3416d3c703b9d1eeb4aefcfa69b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03672812?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-09-27","publishedAt":"2026-08-23","recordId":"NCT03672812","recordSha256":"30e5cca9bed19cd4e703583e4795c2a9973255eb190287ce2f80a73b83f98bdd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03672812?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2024-03-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-03-01","publishedAt":"2026-08-23","recordId":"NCT03672812","recordSha256":"2b0193d13267b607a95677a1208dc0bfac50c96a7c34e65b797406badac7c072","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03672812?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"a1cbe787a6b70a2723abb07931980b837c8ee7528ac580f4b7a6ee700181fa9a"}},"nct03737240":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03737240","recordId":"NCT03737240","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03737240-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03737240","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03737240"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-11-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-11-08","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"6cbfb4506c800f7c9c0df3b161af0b621ba42294af04ce41d586e87f0eb369c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-12-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-12-17","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"b2005cb25ec56f359bb83b6633dffc1e87bd5e1ec6303360773ef53a7972c947","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-01-24","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"60f18bc45137100bd8e720bdb9496550b8e23f63bd22f86dbdba6d9eb3043ad5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-12-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-12-14","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"c37d187d06972918669ac7e0ef57c02a69311d7af544fd17aa5714ab0db3977b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-05-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-05-14","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"fe5e1ee7991c2e01d7e20329585a8fbd1753a4bd34e6364743bf21caf91e6f9b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-05-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-25","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"262359b2a1c3ef7f67f3d6e370ad25edca4418dd5707eaaa565a48ae77ba550d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-03-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-22","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"adb908fb4a3b6c93594c60605df8ed0f8b3b85fa6c8abba8da0af7f7e8b8272e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-08-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-08-04","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"e5310be6eb5a5221d43e79e2a079b9585c213d9290270a69c876b71af6435972","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2023-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-03-14","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"707077ebdd4842f445512d4a42b9cc2d35b335dff87279e5070daccd6af35b4f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-08-15","publishedAt":"2026-08-23","recordId":"NCT03737240","recordSha256":"dd51993864d1186b1a47e831c2c05404ff0a044fcaf18e685562f877165616df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03737240?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"3f19fbd3cb54088ef61a0609b87f550d06c63169a6a8ab2e17261a4b3f4caa7d"}},"nct03795701":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03795701","recordId":"NCT03795701","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03795701-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03795701","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03795701"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-01-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-01-03","publishedAt":"2026-08-23","recordId":"NCT03795701","recordSha256":"e0495edaf21d2cbf388e9db48c9fbfe693ebce383f1bec81f43cce52d17adcc8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03795701?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-08","publishedAt":"2026-08-23","recordId":"NCT03795701","recordSha256":"6f7c6569917cbbac4da2f10d075b0f45c36746c1bffd6fde2227c09075b18f21","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03795701?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-10-07","publishedAt":"2026-08-23","recordId":"NCT03795701","recordSha256":"33c4a63072b7d4f081268fbd3e2e6c7a0667f1598b4e4bbde5251d9c80cb7f2b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03795701?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2021-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-09","publishedAt":"2026-08-23","recordId":"NCT03795701","recordSha256":"28a931eb5b7a87b0554c7cc14439e76fee6d296ee9eb6e2a4eea82a55e6274e0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03795701?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-11-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-11-01","publishedAt":"2026-08-23","recordId":"NCT03795701","recordSha256":"bdf5271c6e8fe8e73e158f6ba2c29ec6990ab5d53374c2e411316073256edff8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03795701?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2023-11-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-11-30","publishedAt":"2026-08-23","recordId":"NCT03795701","recordSha256":"2e5eae07424e45e4c38cccd4101395456819dd5929b409cfefbf0b04634900cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03795701?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"9c044ab3231023fae5eb92da044080354a8997cbf5bec765c265a52742ca7726"}},"nct03856632":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03856632","recordId":"NCT03856632","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03856632-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03856632","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03856632"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-02-26","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"d163c9f3630b3db627a75b951c0182e7a12c8a506b614bc4761fb23875453cc1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-16","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"d913d3dc9366a245e5934d32478994d30769108808a85b0d3f019dbe5e6e9be4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-12-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-12-05","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"77018feed3002818f1f78ca345e9a0856dab4676d0e8bf34ea4dd2a33e30d73c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-06-17","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"724b5004ea8f83a6fa57291787011129306ef42af3382bb2cc1cd461f4502007","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-12-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-12-21","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"928571500da1e4355382679b8db4d4a0b3d9734dd02c94fd4da8ab098aaf8b56","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-03","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"8ab18ed88bebf0a3b39162c2bad6c4660246fb9b8b3d5048c1d5c97e95721c86","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-04-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-28","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"95e0411c75cb082da59dfb7063ad590fd2ed1d43538402f88d17e54bde53ca2c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2023-04-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-04-18","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"b4727fe72e1d0fbb069c56ab38957574f78500fa9a0292f01a3f0fe59d95a30c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2024-03-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-03-26","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"df7d1941060282fcc9c8a373ccef7562cda16408e3b9e7870901a6c18ea5729b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-03-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-03-17","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"0ebedfaa49d39217d95742148ebb7ff156254c17246a2f83babf928f3da74d73","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"fc1810bd71e751a8fd184db7a7e4bbd9b1b221f83f5f4c884fa8b28b782b3aa8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2026-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-04-27","publishedAt":"2026-08-23","recordId":"NCT03856632","recordSha256":"1516c54b004080bc31b5f9eef4ceb0546a6aca0ff587e1d87c7a19d551af3f1d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03856632?a=12&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8aafc3e1fa4f7ebb6c4b61093056732c96080f16ef4bdbcbc0a7b81e93ec7ed5"}},"nct03883412":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03883412","recordId":"NCT03883412","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03883412-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03883412","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03883412"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-18","publishedAt":"2026-08-23","recordId":"NCT03883412","recordSha256":"8bce0394b900f81527a6ba521f8f2a48f9f4063ae7096d793d2836ed305cb9be","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03883412?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2020-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-09-27","publishedAt":"2026-08-23","recordId":"NCT03883412","recordSha256":"ea0ce57998c2c2a38302bbeeca3700adb112735f2f7f9dd0df057bf83262a5c6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03883412?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2022-03-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-07","publishedAt":"2026-08-23","recordId":"NCT03883412","recordSha256":"2b5eceafe85066b73da804aaeb50f048c570a1e4b45e245e0b2f4d29b13b74b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03883412?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2023-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-12-19","publishedAt":"2026-08-23","recordId":"NCT03883412","recordSha256":"f56635346916e346d86c4396f53fcd6a1e1bd0e1becd071cc95dcb70d5ff694b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03883412?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-08-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-08-10","publishedAt":"2026-08-23","recordId":"NCT03883412","recordSha256":"84455ed4d7751955f28131dfa1c440301bb3448b83d5ffc7274c5c7dd84c2a50","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03883412?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"c370e763f0628a7bb7b180202192dee8f9fb3ed393a7b14c31ade07691b5a52d"}},"nct03936049":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03936049","recordId":"NCT03936049","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03936049-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct03936049","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct03936049"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-30","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"7b886026f72e5f1d2e93a534da097a26960fd84456d27a8a2f0efaed4da69f04","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Document Section","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-06-24","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"5bd0e6d3f3e94e87ec1ec69b6c1805bcd322432b5520cd01ad73470573514b65","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Document Section","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-12-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-12-30","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"dbb0e8b12b974644f1bf5167dd2f6d9e9cc8e09447eb29ea73bedcc8179622bf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Document Section","Eligibility","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2023-07-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-07-25","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"070c642b7757eceae37e79a1e7fee250c8b21f629cd74deea730d0df0ce134b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=4&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"47dd6e9a4ddf39c0231484c0ff07c1b25cb69abc9fa0674dfee570d36f98d061"}},"nct04605861":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04605861","recordId":"NCT04605861","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04605861-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct04605861","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct04605861"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2020-10-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-10-21","publishedAt":"2026-08-23","recordId":"NCT04605861","recordSha256":"a6994e68910848b295b7f1ec62a2380fb3e6ee5bd63e3e86c2ae40b3456ae34d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04605861?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2020-11-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-11-02","publishedAt":"2026-08-23","recordId":"NCT04605861","recordSha256":"95f434b2a198ef5470b0d3395f092d20bc2160adc1fda3279e1c3c35b082339b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04605861?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2022-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-16","publishedAt":"2026-08-23","recordId":"NCT04605861","recordSha256":"d843f8749bb05d77ca5b647378785bc0545effe67fc2744a6d695a574d7303d5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04605861?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2023-06-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-06-05","publishedAt":"2026-08-23","recordId":"NCT04605861","recordSha256":"52463469be8ffc5d8180e11032b81a2f9a716d2d4b144cbaa3cabefece5e0556","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04605861?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f0de95390259d28951459ce4cc86ed97beb74b8fd47e2d528205f2c6375dd149"}},"nct04775082":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04775082","recordId":"NCT04775082","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04775082-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct04775082","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct04775082"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2021-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-02-26","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"183c4e5abedf025e5e52e580ffc5d1cac803c9be6cebaaaa4fed9638f19d147b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2021-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-03-04","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"e04ebe2b2e1d5f89b0ed590eb175277df58563b51fe96232451fc0955a130f3e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2021-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-03-12","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"f2f6e2ec5cffde4155a701b98f72dc36e6c2cb230f7ba783f13b09a476e0e082","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2021-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-03-18","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"f7a70df64a5d425107a20f255e32b1ac31f08dfee67922c8631efd6c5b7d2ac2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2021-03-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-03-23","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"6590fd63c46fbd20f8e1aef16fab5741f6017ad0b48c16e70d2b1ae5067c396c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-04-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-04-06","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"e6c27b3d65bf346589cbb6ffb404ab74e01c49b241ccc8775e9f91c4c565a975","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2021-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-04-07","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"47f68ef721df90b30f242c26e98f3ecafc09e4c296a342dfa8358d2ea0102dc5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2021-04-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-04-14","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"fa13641ec3fe262f7d2510c9efa6315cb12f2ee8accb30a6125bb423c05b0d7b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-04-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-04-21","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"8fb4d52c13e0f7348d1d115612000690289e03432f38139733d26a55a9b7988e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2021-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-19","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"927fbdfb520983c284ffd7bba35e3244988f4a03955296efdb88ba2c74298209","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2021-05-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-21","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"5934a28337ebc4d2305b562b2c7b98bd73dbf99890de47fa8c43b79e9927ad93","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2021-05-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-25","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"5d0c5006bda1cbac14f9290478819fdf2d189e7a59772c65bd7a4fc56bf58b57","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2021-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-31","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"19c3bd39554a2ba98760ef1b9bade9ba9705f70ff06be8e795494509e153d1a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2021-06-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-02","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"a4e80e8c2157f0a4a87a0b97b7d7bae2a9d98810a547d096615e9feccaf86630","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2021-06-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-25","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"4331de38dc42129aafa73e7367729313d2a728fb55e0001c7376b0f5de1bb144","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2021-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-08-11","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"1ba822d9cc7a43c223c24167ff1a566da554a79052b51e5cbf46b6ccd0f0b7f4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2021-09-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-09-02","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"c2459efe72bc371615e21c720f0588b208c798edc5d1a28f4aa680f1edad24fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2021-09-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-09-22","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"26f83595850412b6f5196dd8280a5ddfd0b59e361e1c36b60699c3f8537a459a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2021-10-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-14","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"1d4fa646e223a4f7291b13d5ee6c64ecea0597525613ac624e53d0bb78b08e35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2021-10-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-18","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"dc701a1c56e826a2e33efbcf6400998fe7845bc3fd0411421b4bd4ad54b4d76a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2021-11-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-03","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"cda97b6884156133c4cf1c24d3db98e48e91e43612274e33f40350a8fbfcaafd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2021-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-18","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"4fcda8e1ea2678870863ff039cdcdbd810c7bbf09506d6fab95564b40a452eb1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2021-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-12-15","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"9113f90eee6b61211bb3d86cbe195062a887b840732f5330df2fc2d13c1263b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2022-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-01-05","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"17bc4617048d676a245a4d0741584fbba7d716c1d22b6ad17f746afaa8b6feff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2022-01-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-01-26","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"0bec31e68b2453886f4380b2024b50aeffa4d8c1f108c1f6472c677662d2dd23","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2022-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-02-14","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"a24cbb58daeb6dae80dcecb700ad3eae0ddb8636e7313eaa920636f1f4ecc1bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2022-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-14","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"e19c07065adc396ba31adf65ae074ff18f85dc1de3c8fb0270d5c88df943557e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2022-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-07","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"7ac0dba9a51bc048397acd08cd8ac8dd3e807406230cf9083505662c4ce335bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2022-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-11","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"ba1c33340d2f51bea33119657bcb9ae38e32de8b8dcca32d07f59ce3e0f99119","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2022-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-20","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"4b376a72f8884f487de74aacb6f1fa35dbfe27eb4676fc61117d4b7fab579475","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=30&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":31,"lastUpdateSubmitQcDate":"2022-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-08","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"882739689486dd1d056f5a753a1a62afb5d6b73feec5ad9fc7fed11d6aca237f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=31&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":32,"lastUpdateSubmitQcDate":"2022-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-11-10","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"58b5a7151912fd64e26d1bc084501303d8702b9dee65e81a333bb4beeb6a0972","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=32&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":33,"lastUpdateSubmitQcDate":"2023-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-01-23","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"a8b4ad2a8aae7594d145495ac5269d96ebfb7da29be85c22e6b3fd2565fc6e82","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=33&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":34,"lastUpdateSubmitQcDate":"2023-02-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-02-24","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"e663b25e9b2302e56219481f7c66ee6832d73a68db22f6a930fbf6975a544591","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=34&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":35,"lastUpdateSubmitQcDate":"2023-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-04-27","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"f751e94fffc3b61b82bc4bb3ffc56f62866af21a79cec3c0bb8e0854fbb018ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=35&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":36,"lastUpdateSubmitQcDate":"2023-05-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-05-29","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"65ccd1865b2568ce90ab5d6c450534df13d8e7a826612c8c314f33366d72c369","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=36&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":37,"lastUpdateSubmitQcDate":"2023-06-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-06-27","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"20db363685e2c12a651eae760eeb85837c211982ca75a18329e63345d3d1f090","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=37&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":38,"lastUpdateSubmitQcDate":"2023-09-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-09-07","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"de5aaf375e033cc63f0ec9f4dfd7d9e95ed978f742a8c47f2bcc77e01cfacc9f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=38&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":39,"lastUpdateSubmitQcDate":"2023-09-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-09-20","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"684ffd3255eb9dc2bb10d6efd6866b16cda86d7a9816f3f12ff28a2f64d26d22","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=39&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":40,"lastUpdateSubmitQcDate":"2024-03-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-03-26","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"a833ffd1bbdacbf913c3adf0dcad8ed71e70f02980b1eb8ec9382d119f13746e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=40&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":41,"lastUpdateSubmitQcDate":"2024-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-04-01","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"61c3c2db2c002c406b0d79909bb6475b23b257bd99f0eb9ff2ffd6fb56bde5dc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=41&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":42,"lastUpdateSubmitQcDate":"2024-04-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-04-23","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"e0a20a4ab824d23b1328a86ecd0bb7655a3db3c0d6d724f3040378a5fb915a4d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=42&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":43,"lastUpdateSubmitQcDate":"2024-07-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-07-25","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"c6d5cb1a1fd53d30b1c398c66cae63c3d169a04ab02b13789dbed09702614239","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=43&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":44,"lastUpdateSubmitQcDate":"2024-08-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-08-05","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"890e2543131cbec390f7c0ff0dfb50bd76cc7995aad3a4fc25dd8a13d1949026","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=44&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":45,"lastUpdateSubmitQcDate":"2024-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-08-15","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"03f25991af758bf0f3da25f995247f27f6daea0461ef4a5f161a6a9d5650dcde","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=45&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":46,"lastUpdateSubmitQcDate":"2024-08-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-08-21","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"c8b947e1e9984a511acf7a7eee44a841e534bbf6c4df3becbfcac1dc7ca84779","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=46&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":47,"lastUpdateSubmitQcDate":"2024-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-12-19","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"86ff46b1aff145171951ddd25e6075b0c57d13ad2604a4f7bb606fc4be9e7484","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=47&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":48,"lastUpdateSubmitQcDate":"2025-04-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-04-14","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"94ef29c8e6507a7a1e73b191055bac6e163d5a3b693d86d32b9d58b2b2bccd4e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=48&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":49,"lastUpdateSubmitQcDate":"2025-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-09-01","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"430d70a90045c2b760d39745627d72d2cf7f87cebed5442e00c2aee8fb6a7dbe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=49&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":50,"lastUpdateSubmitQcDate":"2025-12-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-12-03","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"32282332a1e574cb22bf77b087fcf4c76207f17655423ef31637fe3e7684c1bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=50&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":51,"lastUpdateSubmitQcDate":"2026-05-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-05-18","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"2ad092dfe0e4bc49fc596c6b9364fa3f20ff25b3a1ed53ee1af839cb278efaf2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=51&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":52,"lastUpdateSubmitQcDate":"2026-07-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-07-08","publishedAt":"2026-08-23","recordId":"NCT04775082","recordSha256":"b7a1760ceaa767a9c6816d62b7a8a29c02c97ab824967cad2fc1645e874424d1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04775082?a=52&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f59705827eca29e97a942ce8100c54556f45f437fe5f23ca666ec0a6a6ab305b"}},"nct04881110":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04881110","recordId":"NCT04881110","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04881110-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct04881110","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct04881110"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2021-05-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-10","publishedAt":"2026-08-23","recordId":"NCT04881110","recordSha256":"471acb4084b0bb36f7f576e4924f7a1cd55ab89c0419c9c3cb59b61688b38a0e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04881110?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Description","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2025-02-12","publishedAt":"2026-08-23","recordId":"NCT04881110","recordSha256":"36a30ed550486fae79ce980862faa7a1935531f1616c517b8263bfd2d29142bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04881110?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"68b1240020b6619fb262831bd7f58d4596aa2bd8e23fe2e1b40e0c841bef4a52"}},"nct04883346":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04883346","recordId":"NCT04883346","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04883346-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct04883346","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct04883346"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2021-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-11","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"61e0f3cb7419950c91e572f83d27004b34fc9f1790d97208cb2a8787af538826","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2021-05-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-12","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"f53b4324aec91284eb5ade70932685293fdd80fb568a29dd9fc04d21c15f092c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2021-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"3242ce40779bcb0e16ac80194a23f25e73e0bc7376247f442fa984335f1127b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2021-05-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-14","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"98eb384c73a8808052b74b2b73a7b7b62b64fe5eb2173af61829eba85c687a87","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2021-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-15","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ad7c32aa36d3a6a31efe41e2dc380af88ae4d4d345498f8d6da4612268b98bf0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-05-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-18","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e86937254d6e4310983ea24f15f03abc9b1aa02226005117fcc58699929a5f87","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2021-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-19","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d5650d37896102bcb682a22ab50a455310e64de3f8927a1baa1a95e9ef951d7c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2021-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-20","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"f544e632b892de64e4911a320e216fd341bc391d79c60d2707e299bd49366c82","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-05-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-21","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e991358f8a867880c8835ed7ea34ba99ce9ebb26a8b7a4247d7be8ef304cbda5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2021-05-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"29bb74d8b1fcb8c59b9da182af3fb987d1360545ddd0685354c9c6c8497e387e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2021-05-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-25","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"1459ffb036baa33271da092274324525b1f864e1b3f14ff264229424806c1ace","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2021-05-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-26","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d596da5bd0a0e7c6804c4a62ca68774edee5abf7d92082b18da2a06bd73b11e6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2021-05-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-27","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"bd47e4a0a9ada4f1733b0c8de74e7ccdb5bb1a1f3a1f853e8c291cb9dff61ac7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2021-05-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-05-28","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d043f3b5578e6000d1f0f86b147f4df63599a1016ae11dc5852bc5d6e32f50d5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2021-06-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-01","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"658ed46c6b382c0a03b6922efb02dbdfa8c19cf95afd6d70c8ebdd12bd23d441","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2021-06-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-02","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"22e4d628e7f85e1b48679b2c115a8b45695b53be9adc135d31f81c868a9984b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2021-06-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-03","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"7a678b6a9364e1655ad5cd72855bd712e7a314ec74c34de7143d4cc38e4154ce","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2021-06-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-04","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"820892c9826acf116d4b89f431021de2f61744fa06c6f25f4aeed121fe2da657","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2021-06-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-05","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"293f34a2f29850298378869ed7b46dee0cb34893aec00d9bf334399cefcfe1a6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2021-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-08","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ba5039a7be1c28f8137e34cdacf88f7d407b27886fa96ff541bb51c65623ad2a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2021-06-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-09","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"7b54ceaabba3c0c05a58d6ebbea33b50520c820177fbb1b47e4540a46e6f6f4f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2021-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-10","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"77fba84ebf3d5e586ec6e3a14fe12ec50a018455c0446ea320405aa909fcc860","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2021-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-11","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"3cedcf5f3237cdc3bebd0c5fd1f10eeed309aed95c1e8f42ee52ffaa302ca27a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2021-06-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-12","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"608471413de338746bc03ca251de6e00c7d3ede2fbcda1b16fb55275ac5f9e3e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2021-06-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-15","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e3d14bf547ebaf3052abdba939a41d0247069051916e3747f917caeec6917cca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2021-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-16","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"c09e2bcc7ab90e79af5ebf615fedc70ec70156ab92f2a029c5ba97727b4d4172","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2021-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-17","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"58a11cf9f1cc5e9f96f34670fc7c6bc5c8c2c3d675cdbab33ffaa1142e53a674","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2021-06-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-18","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d0f47c48dd1576887fe2065b8c4711caff3805dd389158cc536c04af644bc3bb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2021-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-19","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"b72cba984ed728553430a7232f6bfe825ce2743695709bd026de9d077c955663","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2021-06-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"878a0823ba361ae910bca2367a3c4e70f98e4a68a76818ab3c8874d3fc69be75","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=30&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":31,"lastUpdateSubmitQcDate":"2021-06-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-06-25","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"9ca225d188a403f50094366c1f1b468795caeb69d4ef224502ac4f171893379c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=31&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":32,"lastUpdateSubmitQcDate":"2021-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-07-02","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"760a0d12bd6642d3cdd4294d908932d7ace3c05bf83bc1927e149fdeba9e6eeb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=32&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":33,"lastUpdateSubmitQcDate":"2021-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-08-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"78d746e0a66f2cb18ae430aa072b701fe670d1ead5a55feb463af0296141a711","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=33&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":34,"lastUpdateSubmitQcDate":"2021-09-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-09-21","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"9e0535d297a1e4e0c2121eea421303aa7b42b9b89ea61b45ed2a80f71c378702","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=34&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":35,"lastUpdateSubmitQcDate":"2021-09-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-09-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e19859f6c766cb869440861170ecd2504f7bba5ed9ac40fdd2074157afe3ccd9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=35&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":36,"lastUpdateSubmitQcDate":"2021-10-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-02","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ff1553ba95d96d533d60220cdb3962ff69ece671f6f381baa276a41adfc2758e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=36&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":37,"lastUpdateSubmitQcDate":"2021-10-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-21","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"dbca886f3037ff07c1fbaf2a6d4d2a72422341c8007486d9fa86f736664659e0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=37&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":38,"lastUpdateSubmitQcDate":"2021-10-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"4669bee7be4db4a50b73d643619c77868222f7ba325b7fe53bcbef25493ac332","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=38&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":39,"lastUpdateSubmitQcDate":"2021-10-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-10-23","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d1e9451aad04de3f8667bd60c4ab2e6c91740ebc1830b3a7972965d8a1b769f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=39&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":40,"lastUpdateSubmitQcDate":"2021-11-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-24","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"abc71f4347c8ee42b2e02de7d341f8c71ebd9a377a27eb2b752988921f68b29d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=40&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":41,"lastUpdateSubmitQcDate":"2021-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-25","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ba4fde857aeef064fb9376204541ddfc39bedab20b5c6e8a84045da4816988dc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=41&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":42,"lastUpdateSubmitQcDate":"2022-03-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-15","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"6cd5f958331aa7b644d7e140dbc9e0aff5e42de21be7f56cd026c220fb32964b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=42&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":43,"lastUpdateSubmitQcDate":"2022-03-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-16","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"925c3f0be5cbcaf82a2e0e004ba7c72223d1b5b1e7b88db416d0df7ef078e86c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=43&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":44,"lastUpdateSubmitQcDate":"2022-03-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-17","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"56f5b9d8ab2c3dfbbca10cca06e7858e0fe6e3def017c39e666bbfe156515ea7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=44&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":45,"lastUpdateSubmitQcDate":"2022-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-18","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"a321af0d9704695f76d5854709cec400ca97d591b35c228e5769d3000768d687","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=45&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":46,"lastUpdateSubmitQcDate":"2022-03-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-19","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"dec750efff7ab2088be798a8baef6569963650b9e979a6009ce917e9125ded4f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=46&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":47,"lastUpdateSubmitQcDate":"2022-03-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"cb69e65de2500372afaccd0c980c328e8e1160d765580ffb8ab528d4d9601e48","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=47&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":48,"lastUpdateSubmitQcDate":"2022-03-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-23","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"b3ee237801fc989771fcd4ad9c95042c71a5729f0a293d90e1e9a005bdb217d0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=48&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":49,"lastUpdateSubmitQcDate":"2022-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-24","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"561e20f812def756b0efc0bdb0223e9b132e23539f8d658648129c2d8d70df90","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=49&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":50,"lastUpdateSubmitQcDate":"2022-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-25","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"de02476e8dbddc2a1e0172a932681df318aab081f496e19c64982184bc2617e8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=50&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":51,"lastUpdateSubmitQcDate":"2022-03-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-26","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"3aba58b974429c406a3033ae11371d2887ad2a9ee6ecc0f9fa124f88fb8d4c7a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=51&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":52,"lastUpdateSubmitQcDate":"2022-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-30","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ed206a41269e0d8e4328dd852b6153ebdf5ac435ad841a16db1c5a8900955873","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=52&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":53,"lastUpdateSubmitQcDate":"2022-03-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-31","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"8ef21c44117d85d7eff80e35530ebfe6be72b0708f7a028fb10aa7732b8dbc1d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=53&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":54,"lastUpdateSubmitQcDate":"2022-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-01","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"eba752f897ecec5439fb19c56284956a6ce9abbf3fe85cf13ddee22d368d682d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=54&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":55,"lastUpdateSubmitQcDate":"2022-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-02","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"69e37e9d42835138373d999dc3ad1a7e145e2d5abda8f41700599fc05bd1224f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=55&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":56,"lastUpdateSubmitQcDate":"2022-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-05","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"10adc037263e9cf2ad397503d03fadf7f8765a07738c3945726aa1f1ac02131e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=56&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":57,"lastUpdateSubmitQcDate":"2022-04-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-06","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"385d1b890ba40fd7dab86707d08b1d96b5ea03743718940c57bd276e28a2a0b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=57&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":58,"lastUpdateSubmitQcDate":"2022-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-07","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e2d9e6fb356e497623bbd0b97504fdb0a2e1c3295a98a850c16ad10450dab1c9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=58&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":59,"lastUpdateSubmitQcDate":"2022-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-08","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"cfbf570782ff68331b66bb23eff25b9180f42b92bcd1f98d6413e9931338e280","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=59&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":60,"lastUpdateSubmitQcDate":"2022-04-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-09","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"86a5e660609bc8a8de981902cbadeede5319392bc755e28de0debe2673429585","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=60&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":61,"lastUpdateSubmitQcDate":"2022-04-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"538b1afa8a75bbb4c3458db6eee2ea1d107af52fbbd051d990d88598152e25f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=61&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":62,"lastUpdateSubmitQcDate":"2022-04-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-14","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ad0b92bbf8e96b294d3673212c68a8d57797193800bd2d4f19471f6f6e32bbbd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=62&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":63,"lastUpdateSubmitQcDate":"2022-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-15","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"8e3b3fc334d5345fce6e22c4df61689a0640eba27d4b3b7e1419b5dc70a3ccf8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=63&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":64,"lastUpdateSubmitQcDate":"2022-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-16","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"a2bb25354731899c444ebed290367cb069d36c3d4748cbfa23fc9146c0118deb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=64&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":65,"lastUpdateSubmitQcDate":"2022-04-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-19","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"352a7bcd6322181a7c3a1b29c18cd797a7cc497b7491aa2026e0ed5a57b3c518","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=65&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":66,"lastUpdateSubmitQcDate":"2022-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-20","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"16d326c0cc655ab0b4fd13b34c119e761114eb9a3784f0a40c183f5251b1da7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=66&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":67,"lastUpdateSubmitQcDate":"2022-04-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-21","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e34010118ba15096ce3047017c430142a352c0598a6c3470e7fa9ecbdbde4832","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=67&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":68,"lastUpdateSubmitQcDate":"2022-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"3d605d7c40b971034c5fb4b6cf3fd2bb834a98cae0c42d0004f91f9afaeab96f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=68&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":69,"lastUpdateSubmitQcDate":"2022-04-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-23","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"5261134d4a2cfb5053d970efd94ec1d0235bed91f167793045293877dcd865ae","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=69&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":70,"lastUpdateSubmitQcDate":"2022-04-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-26","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"da399c1730af3725994c488f0d13fe5dd8544f8de12b02dda8098aa48c95d069","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=70&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":71,"lastUpdateSubmitQcDate":"2022-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-27","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"aa98645460c67bfeefbf5f3fa5fa653f146587c1821e15ee06c0714049ae1aae","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=71&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":72,"lastUpdateSubmitQcDate":"2022-04-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-04-29","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"b1f4090f7a16a950182b2596886b8bf2028c928d29058c182b38ef46b64dffbd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=72&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":73,"lastUpdateSubmitQcDate":"2022-05-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-02","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"4dba7ad844927a5bb812ba63eaa3b29fc610a311ce7893c19ecc59e197f298b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=73&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":74,"lastUpdateSubmitQcDate":"2022-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-03","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"2bd3cb47ed2eedb7846229fe4769334359f485e82684a1ab7675df53fcbeb208","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=74&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":75,"lastUpdateSubmitQcDate":"2022-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-04","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"fac529ad43d5cc3922eb5390c6fd7c04c46e32bd73671189b7593f81ee47184f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=75&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":76,"lastUpdateSubmitQcDate":"2022-05-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-05","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"42c57a2882b9d94d3fe0aee18d2e2ed5e3fbd2af96113bdb87fe465696a57194","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=76&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":77,"lastUpdateSubmitQcDate":"2022-05-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-06","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"3861fb9d9a7ca91fd4f304730ae3a9789bf9eea803c1822f45045e49e11b9492","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=77&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":78,"lastUpdateSubmitQcDate":"2022-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-09","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"1562ec9ff7c068235464adca3662270daebd7205406ce51825db61aa03a7b4a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=78&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":79,"lastUpdateSubmitQcDate":"2022-05-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-10","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"982075e480bed2149c51de7a928debfed63e9d88d9b2ae422b881c69592e18b0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=79&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":80,"lastUpdateSubmitQcDate":"2022-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-11","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"69d3196c2b1a84bb0407e94f4ebded37a780e62dc63bad87064ee3abf32cd53f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=80&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":81,"lastUpdateSubmitQcDate":"2022-05-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-12","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"8c98ccfe3db0a9f2618048ec7c773765b915996093db9b8510da1034441dc7a8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=81&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":82,"lastUpdateSubmitQcDate":"2022-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"6c177313dabd1d10a60d306dfdc793cccd47c9c3689ea665197c764a0c50723c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=82&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":83,"lastUpdateSubmitQcDate":"2022-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-16","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e116892b0d9da2bd8169b63cb62eb7907388b5bbbfe0bf46c47c7325eb154fb9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=83&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":84,"lastUpdateSubmitQcDate":"2022-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-17","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"21941ae019255ebfe6cc7621e26a4d7e9d031181eb5adb84c4d5219391dab933","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=84&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":85,"lastUpdateSubmitQcDate":"2022-05-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-18","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e7f54faa8caf1447ea7d0b56098715d471271fb05137fd37c99e80785ee2ce73","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=85&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":86,"lastUpdateSubmitQcDate":"2022-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-19","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"3ba1f125340005b073fbe7acc48142debfcbc818904bdc1805606386ff7af8f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=86&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":87,"lastUpdateSubmitQcDate":"2022-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-20","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"c11100bd4349c7921944ccabd069d01c52d625ccaa1d7e9bcd660dc590cfe611","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=87&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":88,"lastUpdateSubmitQcDate":"2022-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-23","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"0a7c98bfeded766d5a0e6ef39a8dd6371e8d85d9b37471576224b69482ae19a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=88&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":89,"lastUpdateSubmitQcDate":"2022-05-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-24","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"2e781ee73d5e591b47880f1d0332c7fdaca8bb3273635c607e2fe33e7ba79165","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=89&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":90,"lastUpdateSubmitQcDate":"2022-05-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-25","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"365dd97991f67a7b345cf5c1358f24f8161a7668697738eebe8b4ec6639c2b4e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=90&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":91,"lastUpdateSubmitQcDate":"2022-05-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-26","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"73b8eef7d365ba21df8246a9f9c6325d54c8bb21ae97f599b866e6ff49583cf6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=91&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":92,"lastUpdateSubmitQcDate":"2022-05-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-27","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"1604a4cace01d344f7cdc3ece2fca09c3d19b5190d717ce3128949e53e9de63e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=92&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":93,"lastUpdateSubmitQcDate":"2022-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-31","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"b8ed70731e18b64d0333edf1963d26885d9fe1e8538ec8fa5909333781388894","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=93&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":94,"lastUpdateSubmitQcDate":"2022-06-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-01","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"2c50089de6edfd0fcfeae0223e9af49b8d2d1278a2bb5b7139aeb7b3cd3270f8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=94&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":95,"lastUpdateSubmitQcDate":"2022-06-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-02","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"32bfec4c0992a31fb0e194c011748ac395f3884ea0528a8e55bd96c6dbef6a57","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=95&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":96,"lastUpdateSubmitQcDate":"2022-06-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-03","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"79b1dbda25edd050fdd09e22078b744bfa1a44a514ae8c970610309a6c7777a3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=96&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":97,"lastUpdateSubmitQcDate":"2022-06-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-06","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"854c407038b719ebe805587ace31ce1497136638bbe5377f034ac469666f6c36","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=97&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":98,"lastUpdateSubmitQcDate":"2022-06-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-07","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"5931c51be3e0732e23381775a6daf9be40c73fe34e9af64498d32ea14205de56","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=98&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":99,"lastUpdateSubmitQcDate":"2022-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-08","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"f297c88b312d76f177cdae5e3d1a88ad6dd14777100265f11f874e41b530b2c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=99&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":100,"lastUpdateSubmitQcDate":"2022-06-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-09","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ff24098fce39894c74568b31e25bf0227628bc22f7b99b36ee1679a1e7931073","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=100&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":101,"lastUpdateSubmitQcDate":"2022-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-10","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"6a266ff9702a3815a0465fe07c35bf1c7594ef11ee9688de4a135bb30b400dca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=101&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":102,"lastUpdateSubmitQcDate":"2022-06-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"9353bdd2c1eb3155883bbf97973acd80e94432d30bd7bb266a983f23ca61352e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=102&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":103,"lastUpdateSubmitQcDate":"2022-06-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-14","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"7ef9e8a9fb874854065b9be883d012b2f02e35a0a8f4b0bf605dd1e0376811c6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=103&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":104,"lastUpdateSubmitQcDate":"2022-06-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-15","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"9bcbc0d3e8aee85b320eced6f051cdc081d9409f9702047d9c3533683f3f66b6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=104&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":105,"lastUpdateSubmitQcDate":"2022-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-17","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"258475643d28a6b72c48cf7a30a75b68aa627f0409cb75fe1ad47a47c04b43c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=105&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":106,"lastUpdateSubmitQcDate":"2022-06-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-21","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"8839164f612122ee436473cda4ed16b6ef27b9e424575637f0cb904b4d5b39c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=106&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":107,"lastUpdateSubmitQcDate":"2022-06-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-22","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"a661ac8e4e3122dfb95c0c0a90f25ac4479ed98c329fab10da3f9f1a23368fb9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=107&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":108,"lastUpdateSubmitQcDate":"2022-06-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-23","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"4d1a5e5f654a5bf325e093d9b90cf0a4fbe6d64b37d5addcf56e179206a35fe6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=108&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":109,"lastUpdateSubmitQcDate":"2022-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-24","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"2935d9b3847b5b8ba0e12c8266bad03a4b5d25a347f53520dbfac7c67f5a3867","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=109&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":110,"lastUpdateSubmitQcDate":"2022-06-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-27","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"57b47758689d608214089bbf6b06460f2bed0afb46b1eabc9e24f3f96068e45f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=110&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":111,"lastUpdateSubmitQcDate":"2022-06-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-29","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"0b8e095dd3a10e5961c8e5a47f44af6980f5155feff2ebe8acdb436609ebb001","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=111&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":112,"lastUpdateSubmitQcDate":"2022-06-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-06-30","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"7527386493daef18de952eab8955373ddb3fe5ec2ae01080e16a6e800dc2b316","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=112&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":113,"lastUpdateSubmitQcDate":"2022-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-01","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"2e6bbd803bbb317e1f27a798c8848ed5db38b722518263ad413d18638aefa787","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=113&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":114,"lastUpdateSubmitQcDate":"2022-07-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-05","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e27b5e256183d977e22d3bfad8b972389214b5cb1d15694e38fc9e36b3b95a1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=114&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":115,"lastUpdateSubmitQcDate":"2022-07-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-06","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"08a79cbaaea0286a4b08da7dfdd1e81f1d664738759b7a9a73ec29c90ffbad54","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=115&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":116,"lastUpdateSubmitQcDate":"2022-07-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-07","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"42929c37cff335952af8dc4a216a078e6d6fc66ce1f638ce46903b1e0ec168a6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=116&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":117,"lastUpdateSubmitQcDate":"2022-07-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-08","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d7762c1f3b353a0b4de3ecede20d4db457a437a9388cbef94b1a6ba2c45b5c63","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=117&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":118,"lastUpdateSubmitQcDate":"2022-07-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-07-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"08b18546a3042db5f081645a42351ba6ac67fac3e2d71e65c4d2552d6d103670","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=118&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":119,"lastUpdateSubmitQcDate":"2022-08-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-08-16","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"0cb1094bb9b91b2172e63ff90f229822c243eca08fa33a4a507be62894a6bbb1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=119&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":120,"lastUpdateSubmitQcDate":"2022-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-09-01","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"7fb6bb9e0bdad37e2e04e364eec2e1f6b9be936811ba564a7c37477c8a4eea4a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=120&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":121,"lastUpdateSubmitQcDate":"2022-09-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-09-14","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"feedb6559567b0766119520e32c3b26941f7a0980d08943d1ae78fb90a19c222","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=121&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":122,"lastUpdateSubmitQcDate":"2023-01-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-01-04","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"36ce056722382464b19d082587d9e8e5653ab8fd39f53867e992674008253ef0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=122&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":123,"lastUpdateSubmitQcDate":"2023-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-01-06","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"6b3bea7dfdecbfb1f8108dde48d04980a6785a0b8fcd2490b69f271e60318ba4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=123&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":124,"lastUpdateSubmitQcDate":"2023-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-01-19","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"5f3b82b676f882d4f0b28b413e5032b8b1bbf39f7d45d26619823752216a80c3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=124&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":125,"lastUpdateSubmitQcDate":"2023-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-02-09","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"31c8138dbf2c6df36623952b22e19ffb8e0b4bfb1ed42a1a484fb83b216797a6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=125&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":126,"lastUpdateSubmitQcDate":"2023-02-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-02-17","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"27fe264a9f50cd99b7e836a06436172ea7b974c987e982152468d8f8ebe27b7c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=126&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":127,"lastUpdateSubmitQcDate":"2023-07-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-07-28","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"d7d39478e100b39054c9742e9bc7157a13a368dc6d35c67482cb81cfdc45ff40","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=127&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":128,"lastUpdateSubmitQcDate":"2023-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-09-29","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"e37d2b921383b67c5ed1b92e175bdbd1b854c888643ac07d53e05097ceaf2b5e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=128&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":129,"lastUpdateSubmitQcDate":"2023-11-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-11-14","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"da63f4fc558834b79cfc20d1ae52b710fb38661a2879639a677e804ab9e28503","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=129&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Design","Study Status"],"historyVersion":130,"lastUpdateSubmitQcDate":"2024-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-01-23","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"52a0fc88da83791add37ad758ba28f4626648f4591f2236611d58c65c6d7855a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=130&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":131,"lastUpdateSubmitQcDate":"2024-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-01-24","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"b7d2e19a056525d32ea0b693275e8336ccbf7ff4dda33f6ca8b808ee2c79d6b0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=131&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":132,"lastUpdateSubmitQcDate":"2024-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-05-17","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"fae3cc2829b194d97c8d7c5008edcd1fdc1b1aafd86fc03151e3caf928c2dfab","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=132&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Study Status"],"historyVersion":135,"lastUpdateSubmitQcDate":"2024-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-11-13","publishedAt":"2026-08-23","recordId":"NCT04883346","recordSha256":"ff9084bef6f77b5bd1834e851dd932907b7fd17b960d041c43aa2393f64d5ab4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04883346?a=135&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"2e42deefbb98979d33cc56987d186e1f5367f86e9fdebbf8f681592a5458a5e2"}},"nct05153590":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05153590","recordId":"NCT05153590","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05153590-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct05153590","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct05153590"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2021-11-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2021-11-30","publishedAt":"2026-08-23","recordId":"NCT05153590","recordSha256":"36091f250eb9c4d61b558f2bac43b890741d6db5959e043556d41a5d3bd4ce10","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05153590?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2021-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2021-12-15","publishedAt":"2026-08-23","recordId":"NCT05153590","recordSha256":"a55efda9439139b9d33df1f237cb3347f852dd9dcb381f41d350206a6fef046f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05153590?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2022-11-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-11-16","publishedAt":"2026-08-23","recordId":"NCT05153590","recordSha256":"12fe7d74f11d9ed9be960659943c5d911d6adaee6b6e8a1ac1341e35bb6c35de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05153590?a=3&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"45ac38469c0c0b358ea0731872f889aab58edfb7591d0726796ec8a7a6d03cae"}},"nct05313529":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05313529","recordId":"NCT05313529","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05313529-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct05313529","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct05313529"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2022-03-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-28","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"fadccd2337c856d850b3bf9f0561f1fbe444c5d5396ad1bedd875099f68da70a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2022-08-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-08-23","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"737faedd3855236e4bbfb7500d0e71456fc7de75aa717e743154c8d89e069df9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2022-09-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-09-06","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"b643bf6b4d2e8dc07e2a54ea6d0e1acc12ad446fbd250c5fb693c129ee17558b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2022-10-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-10-08","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"681942d7d2b11bbbc30df207229b83e2a32ec3641730f236735ac745f836b5a9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2023-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-05-15","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"8b3ea62db744d8e3b013e4cd5e4e8e9cac0a19fe7b06ca35b2b776026921c31a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","IPDSharing","Outcome Measures","Sponsor/Collaborators","Study Description","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2024-03-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-03-19","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"a14cef2952c7c80ffe2162d8803abcc7ed5cc74d958fb7f24f552aea118d6e00","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2024-05-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-05-30","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"5b43a438e362fa4aafd961ca90f9d7ed7b3e6d57f41d0085cf3b05ab88406140","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Sponsor/Collaborators","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2024-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-09-10","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"17edb07fb7a0ecdfacbb5f44e9e19a3dd0b33358c7fc570ac2b6f0cac4c7fb57","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2024-10-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-10-15","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"3aff1620345ace47004aad3c0de18cac4d7cbb50c27e9a72ec5403d8fd9d339f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-05-17","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"1944fa1ca1605aebcc97a37f4bdefea9c818a8ec6ecb102f1840db8125bcf77f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-06-24","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"676eba2471c4182db459c5703ce01d8735a8df4c2f85bd11dbe3e8784b286220","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Identification","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2025-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-11-18","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"144409861e3b1192b672a53dcc1cc969ea5a91b4bd1837a441267f904dfb9fcf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Outcome Measures","References","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2026-01-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-01-03","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"6b4afdf01483aae5cbf79ce79454b520c42b50744783817fa02ce8a25cf6d2b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2026-07-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-07-21","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"f20ab6fd354c7c1c12234afd7b070d8eeb7ff2528d205881600a6bfdd2a6f24b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Oversight","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-08-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-08-03","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"5fa0cb49ba26e3adb6f5c2547f2619775b794ffab54333ec5786bfca8f3a01c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=15&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"65b32a0fa0e40c816af9a0339245cdaf8da6c7041b802d76df83f449beec4704"}},"nct05681299":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05681299","recordId":"NCT05681299","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05681299-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct05681299","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct05681299"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2022-12-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-12-27","publishedAt":"2026-08-23","recordId":"NCT05681299","recordSha256":"6a72965daabce0747ec1cf37f8f8a691b884c28f3e8deedbe37dd737681d1da6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05681299?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2024-01-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-01-02","publishedAt":"2026-08-23","recordId":"NCT05681299","recordSha256":"61af2e81a1a20f2ea14d6eb64bb94666494905a1e75619fb5d9e7bea5a9cd905","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05681299?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-02-10","publishedAt":"2026-08-23","recordId":"NCT05681299","recordSha256":"47ea6fc6e3db0099194bdee8ad6871f2eb10864d76f2280e5410da64c0d68641","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05681299?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-03-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-03-02","publishedAt":"2026-08-23","recordId":"NCT05681299","recordSha256":"35ebea860b52a55ff44c766955f72ba3be826d46f214a32e7eeb9be752b0ce80","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05681299?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"3bf09f8d1f973edaf8d6e5be0f0a4164d0fb4fbc6f2def370cfe9b7f102cc970"}},"nct05965908":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05965908","recordId":"NCT05965908","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05965908-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct05965908","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct05965908"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2023-07-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-07-20","publishedAt":"2026-08-23","recordId":"NCT05965908","recordSha256":"f8697fa1c0c723daba05e6c95e1525adaa8bf134ea33c71749038bf62ffb0ca6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05965908?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","IPDSharing","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2023-07-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-07-28","publishedAt":"2026-08-23","recordId":"NCT05965908","recordSha256":"1a8b02c273d8d44a93253d77b90555c70fff43e6c1c3bbccd5df6a4189239b20","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05965908?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2026-03-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-03-05","publishedAt":"2026-08-23","recordId":"NCT05965908","recordSha256":"55a113cdbebea27db741e86a3d48467936d8675e344697db51bc5dfea9393de2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05965908?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Sponsor/Collaborators","Study Description","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-08-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-08-19","publishedAt":"2026-08-23","recordId":"NCT05965908","recordSha256":"e011cd7c04e828d0cc3dbd39dd61c459edabd0daec29d2f3c9abd923acc730fe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05965908?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"6233af801e3d22c7f4c5192e6baf594ec21617200ba32773686214d57c75f947"}},"nct06099067":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06099067","recordId":"NCT06099067","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06099067-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct06099067","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct06099067"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2023-10-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-10-23","publishedAt":"2026-08-23","recordId":"NCT06099067","recordSha256":"82493044cf9b5a5537e35b1d04738602e0b3a1e0f1c3ceebbfc248e1bac78724","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06099067?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["References","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2024-08-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-08-29","publishedAt":"2026-08-23","recordId":"NCT06099067","recordSha256":"fe737fd9200b26b444e5622630035ec51bde6284bb521d1e288350fe86e61dc8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06099067?a=2&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"c223cdd5b45ace4bfc1460a195611198ab714c1e5d6b12ff257c263eaeddee20"}},"nct06283641":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06283641","recordId":"NCT06283641","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06283641-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct06283641","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct06283641"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2024-02-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-02-21","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"7e0d8e60253fc24c194be1a8db1a2e5d7cefa58a5ee422873ae362da520f1cd4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2024-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2024-04-01","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"331e7e69728b0666858b53abdaf66050b2f1853632873f09ce27bbff34a89090","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2024-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2024-04-03","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"6c202dfc70961bd5b920198f293a33df1335baed25a38357491ad6e4a09780eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2024-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2024-05-16","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"a0fb962085bb60fcf63abc750a71c2eafe4960cb42fdc90282405eadc9d177a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2024-12-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-12-11","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"289129f7387db523ed9843ae23c950d7cda33b636bff6d4cd975fa7eb797114b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-03-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2025-03-26","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"edb26975b0137c9a91df5ad35cb99cebef49a9a8bbb9c1fb154a437b5187192f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2025-04-07","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"b78b197ac97c566afb73127529d359e9a24b4b57e55b06acdb55ac3ed3d4a3e8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-01-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-01-08","publishedAt":"2026-08-23","recordId":"NCT06283641","recordSha256":"24a45a993717c17e5a3f4c8a6285d3c582a1c2cd599079ffb8dc0897e62bf0eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06283641?a=8&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"7bd7e507e1ecba643de76990f4cf9fb3b82cfec8e62dd2c619b9dea7f6f3842f"}},"nct07029009":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07029009","recordId":"NCT07029009","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07029009-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.json#nct07029009","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/liraglutide.md#nct07029009"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-06-11","publishedAt":"2026-08-23","recordId":"NCT07029009","recordSha256":"f263d1599dd542e662289e178c51c190c5e2c9316061dcc3223159c65642a609","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07029009?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-12-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-12-12","publishedAt":"2026-08-23","recordId":"NCT07029009","recordSha256":"3d09889f9bf4cc36cbecfb3010a8005ce0f397f0544182ae7e0f959e25b262a4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07029009?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e1de0e94bcfe71d29449c08b8e4756cfc80d7298f395eed8cad9c8d20cd091c0"}}}}
